0.12555.254.54.7544.252.01.52.752.04.751.54.02.754.754.000P4Y0false--06-30Q12020000102430548100000553000000.1250.1250.010.011000000000.0100000000081920000082250000075420000075700000020000030000050000000.010.010.0120000000.020000000.09400000940000079000001500000940000094000007900000150000006500000065500000 0001024305 2019-07-01 2019-09-30 0001024305 2019-10-30 0001024305 2018-07-01 2018-09-30 0001024305 2019-06-30 0001024305 2019-09-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-06-30 0001024305 us-gaap:PreferredStockMember 2019-07-01 0001024305 us-gaap:ParentMember 2019-07-01 2019-09-30 0001024305 us-gaap:PreferredStockMember 2019-06-30 0001024305 us-gaap:TreasuryStockMember 2019-07-01 0001024305 2019-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-09-30 0001024305 us-gaap:PreferredStockMember 2019-09-30 0001024305 us-gaap:ParentMember 2019-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-07-01 0001024305 us-gaap:RetainedEarningsMember 2019-09-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 0001024305 us-gaap:CommonClassAMember 2019-07-01 2019-09-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001024305 us-gaap:TreasuryStockMember 2019-09-30 0001024305 us-gaap:TreasuryStockMember 2019-06-30 0001024305 us-gaap:AccountingStandardsUpdate201602Member us-gaap:ParentMember 2019-07-01 0001024305 us-gaap:NoncontrollingInterestMember 2019-09-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001024305 us-gaap:CommonClassAMember us-gaap:ParentMember 2019-07-01 2019-09-30 0001024305 us-gaap:RetainedEarningsMember 2019-07-01 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001024305 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001024305 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 0001024305 us-gaap:CommonClassAMember us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001024305 us-gaap:RetainedEarningsMember 2019-06-30 0001024305 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001024305 us-gaap:ParentMember 2019-09-30 0001024305 us-gaap:ParentMember 2019-07-01 0001024305 us-gaap:NoncontrollingInterestMember 2019-06-30 0001024305 us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2019-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001024305 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0001024305 us-gaap:NoncontrollingInterestMember 2019-07-01 0001024305 us-gaap:PreferredStockMember 2018-06-30 0001024305 coty:AdoptionofASC606Member 2018-07-01 0001024305 us-gaap:PreferredStockMember 2018-09-30 0001024305 2018-09-30 0001024305 us-gaap:ParentMember 2018-07-01 2018-09-30 0001024305 us-gaap:AccountingStandardsUpdate201609Member 2018-07-01 0001024305 us-gaap:NoncontrollingInterestMember 2018-07-01 2018-09-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-06-30 0001024305 us-gaap:TreasuryStockMember 2018-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001024305 us-gaap:PreferredStockMember 2018-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-09-30 0001024305 us-gaap:TreasuryStockMember 2018-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0001024305 2018-07-01 0001024305 us-gaap:TreasuryStockMember 2018-09-30 0001024305 2018-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0001024305 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-07-01 0001024305 us-gaap:RetainedEarningsMember 2018-06-30 0001024305 coty:AdoptionofASC606Member us-gaap:ParentMember 2018-07-01 0001024305 us-gaap:NoncontrollingInterestMember 2018-07-01 0001024305 us-gaap:AccountingStandardsUpdate201609Member us-gaap:RetainedEarningsMember 2018-07-01 0001024305 us-gaap:RetainedEarningsMember 2018-07-01 0001024305 us-gaap:ParentMember 2018-07-01 0001024305 us-gaap:AccountingStandardsUpdate201609Member us-gaap:ParentMember 2018-07-01 0001024305 coty:AdoptionofASC606Member us-gaap:RetainedEarningsMember 2018-07-01 0001024305 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001024305 us-gaap:NoncontrollingInterestMember 2018-06-30 0001024305 us-gaap:ParentMember 2018-09-30 0001024305 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 0001024305 us-gaap:RetainedEarningsMember 2018-09-30 0001024305 us-gaap:NoncontrollingInterestMember 2018-09-30 0001024305 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001024305 us-gaap:ParentMember 2018-06-30 0001024305 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 0001024305 2019-09-25 0001024305 us-gaap:AccountingStandardsUpdate201602Member coty:UnamortizedLeaseIncentivesAndLeaseLossLiabilitiesMember 2019-07-01 0001024305 srt:MaximumMember 2019-09-30 0001024305 srt:MinimumMember 2019-09-30 0001024305 us-gaap:BuildingMember 2019-07-01 2019-09-30 0001024305 us-gaap:CorporateNonSegmentMember 2018-07-01 2018-09-30 0001024305 coty:ConsumerBeautySegmentMember 2018-07-01 2018-09-30 0001024305 us-gaap:OperatingSegmentsMember coty:ConsumerBeautySegmentMember 2018-07-01 2018-09-30 0001024305 us-gaap:CorporateNonSegmentMember 2019-07-01 2019-09-30 0001024305 us-gaap:OperatingSegmentsMember coty:ConsumerBeautySegmentMember 2019-07-01 2019-09-30 0001024305 coty:LuxurySegmentMember 2018-07-01 2018-09-30 0001024305 coty:ProfessionalBeautySegmentMember 2018-07-01 2018-09-30 0001024305 coty:LuxurySegmentMember 2019-07-01 2019-09-30 0001024305 us-gaap:OperatingSegmentsMember coty:ProfessionalBeautySegmentMember 2018-07-01 2018-09-30 0001024305 us-gaap:OperatingSegmentsMember coty:LuxurySegmentMember 2019-07-01 2019-09-30 0001024305 coty:ProfessionalBeautySegmentMember 2019-07-01 2019-09-30 0001024305 us-gaap:OperatingSegmentsMember coty:ProfessionalBeautySegmentMember 2019-07-01 2019-09-30 0001024305 coty:ConsumerBeautySegmentMember 2019-07-01 2019-09-30 0001024305 us-gaap:OperatingSegmentsMember coty:LuxurySegmentMember 2018-07-01 2018-09-30 0001024305 us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001024305 coty:SkinAndBodyCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0001024305 coty:HairCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001024305 coty:ColorCosmeticsMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0001024305 coty:FragrancesMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0001024305 us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0001024305 coty:ColorCosmeticsMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001024305 coty:FragrancesMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001024305 coty:SkinAndBodyCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2018-07-01 2018-09-30 0001024305 coty:HairCareMember us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember us-gaap:ProductConcentrationRiskMember 2019-07-01 2019-09-30 0001024305 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember coty:YouniqueLLCMember 2019-09-16 2019-09-16 0001024305 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember coty:YouniqueLLCMember 2019-07-01 2019-09-30 0001024305 coty:SoutheasternAsianSubsidiaryMember 2019-07-31 0001024305 coty:TurnaroundPlanMember 2019-09-30 0001024305 us-gaap:OtherRestructuringMember coty:TurnaroundPlanMember 2019-09-30 0001024305 us-gaap:EmployeeSeveranceMember coty:TurnaroundPlanMember 2019-09-30 0001024305 us-gaap:ContractTerminationMember coty:TurnaroundPlanMember 2019-09-30 0001024305 coty:FixedAssetWriteoffsMember coty:TurnaroundPlanMember 2019-09-30 0001024305 srt:ScenarioForecastMember coty:TurnaroundPlanMember 2020-07-01 2021-06-30 0001024305 coty:TurnaroundPlanMember 2019-07-01 2019-09-30 0001024305 coty:OtherRestructuringPlanMember 2019-09-30 0001024305 coty:OtherRestructuringPlanMember 2019-07-01 2019-09-30 0001024305 srt:ScenarioForecastMember coty:GlobalIntegrationMember 2021-07-01 2022-06-30 0001024305 srt:ScenarioForecastMember coty:TurnaroundPlanMember 2021-07-01 2022-06-30 0001024305 srt:ScenarioForecastMember coty:A2018RestructuringMember 2019-07-01 2020-06-30 0001024305 srt:ScenarioForecastMember coty:OtherRestructuringPlanMember 2020-07-01 2021-06-30 0001024305 coty:GlobalIntegrationMember 2019-09-30 0001024305 coty:OtherRestructuringPlanMember 2018-07-01 2018-09-30 0001024305 srt:ScenarioForecastMember coty:OtherRestructuringPlanMember 2021-07-01 2022-06-30 0001024305 srt:ScenarioForecastMember coty:A2018RestructuringMember 2021-07-01 2022-06-30 0001024305 srt:ScenarioForecastMember coty:A2018RestructuringMember 2020-07-01 2021-06-30 0001024305 coty:A2018RestructuringMember 2019-09-30 0001024305 srt:ScenarioForecastMember coty:OtherRestructuringPlanMember 2019-07-01 2020-06-30 0001024305 srt:ScenarioForecastMember coty:GlobalIntegrationMember 2019-07-01 2020-06-30 0001024305 coty:OtherRestructuringPlanMember 2019-06-30 0001024305 srt:ScenarioForecastMember coty:GlobalIntegrationMember 2020-07-01 2021-06-30 0001024305 srt:ScenarioForecastMember coty:TurnaroundPlanMember 2019-07-01 2020-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2019-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2019-07-01 2019-09-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2019-09-30 0001024305 coty:GlobalIntegrationMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2019-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2019-07-01 2019-09-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2019-07-01 2019-09-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2019-07-01 2019-09-30 0001024305 coty:GlobalIntegrationMember 2019-07-01 2019-09-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2019-09-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2019-09-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2019-09-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringMember 2019-09-30 0001024305 coty:A2018RestructuringMember 2019-07-01 2019-09-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringMember 2019-07-01 2019-09-30 0001024305 coty:FixedAssetWriteoffsMember coty:A2018RestructuringMember 2019-07-01 2019-09-30 0001024305 coty:FixedAssetWriteoffsMember coty:A2018RestructuringMember 2017-07-01 2018-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringMember 2019-09-30 0001024305 coty:A2018RestructuringMember 2017-07-01 2018-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringMember 2019-09-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringMember 2019-07-01 2019-09-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringMember 2017-07-01 2018-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringMember 2018-07-01 2019-06-30 0001024305 coty:A2018RestructuringMember 2018-07-01 2019-06-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringMember 2018-07-01 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringMember 2018-07-01 2019-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:A2018RestructuringMember 2019-09-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringMember 2017-07-01 2018-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringMember 2019-07-01 2019-09-30 0001024305 coty:FixedAssetWriteoffsMember coty:A2018RestructuringMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringMember 2017-07-01 2018-06-30 0001024305 coty:A2018RestructuringMember 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:A2018RestructuringMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:A2018RestructuringMember 2019-06-30 0001024305 us-gaap:ContractTerminationMember coty:A2018RestructuringMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:GlobalIntegrationMember 2016-07-01 2017-06-30 0001024305 us-gaap:OtherRestructuringMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2018-07-01 2019-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 us-gaap:ContractTerminationMember coty:GlobalIntegrationMember 2017-07-01 2018-06-30 0001024305 coty:GlobalIntegrationMember 2018-07-01 2018-09-30 0001024305 coty:TurnaroundPlanMember 2018-07-01 2018-09-30 0001024305 coty:A2018RestructuringActivitiesMember 2019-07-01 2019-09-30 0001024305 coty:A2018RestructuringActivitiesMember 2018-07-01 2018-09-30 0001024305 coty:OtherRestructuringProgramsMember 2019-07-01 2019-09-30 0001024305 coty:OtherRestructuringProgramsMember 2018-07-01 2018-09-30 0001024305 us-gaap:ContractTerminationMember coty:TurnaroundPlanMember 2019-07-01 2019-09-30 0001024305 us-gaap:EmployeeSeveranceMember coty:TurnaroundPlanMember 2019-07-01 2019-09-30 0001024305 us-gaap:OtherRestructuringMember coty:TurnaroundPlanMember 2019-06-30 0001024305 coty:TurnaroundPlanMember 2019-06-30 0001024305 coty:FixedAssetWriteoffsMember coty:TurnaroundPlanMember 2019-07-01 2019-09-30 0001024305 coty:FixedAssetWriteoffsMember coty:TurnaroundPlanMember 2019-06-30 0001024305 us-gaap:OtherRestructuringMember coty:TurnaroundPlanMember 2019-07-01 2019-09-30 0001024305 us-gaap:ContractTerminationMember coty:TurnaroundPlanMember 2019-06-30 0001024305 us-gaap:EmployeeSeveranceMember coty:TurnaroundPlanMember 2019-06-30 0001024305 coty:TurnaroundPlanMember 2019-07-01 2019-07-01 0001024305 coty:LuxurySegmentMember 2019-09-30 0001024305 coty:ConsumerBeautySegmentMember 2019-06-30 0001024305 coty:ProfessionalBeautySegmentMember 2019-06-30 0001024305 coty:ProfessionalBeautySegmentMember 2019-09-30 0001024305 coty:LuxurySegmentMember 2019-06-30 0001024305 coty:ConsumerBeautySegmentMember 2019-09-30 0001024305 us-gaap:LicensingAgreementsMember 2019-09-30 0001024305 us-gaap:TrademarksMember 2019-06-30 0001024305 coty:ProductFormulationsandTechnologyMember 2019-06-30 0001024305 us-gaap:CustomerRelationshipsMember 2019-09-30 0001024305 us-gaap:TrademarksMember 2019-09-30 0001024305 us-gaap:CustomerRelationshipsMember 2019-06-30 0001024305 coty:ProductFormulationsandTechnologyMember 2019-09-30 0001024305 us-gaap:LicensingAgreementsMember 2019-06-30 0001024305 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember coty:YouniqueLLCMember 2019-09-30 0001024305 us-gaap:TrademarksMember 2018-07-01 2018-07-31 0001024305 coty:PricingTierFiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierTwoMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierSixMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierThreeMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFourMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierSixMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFourMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierTwoMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFiveMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierOneMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierThreeMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierOneMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:A2018CotyTermBFacilityMember 2018-04-05 0001024305 us-gaap:MediumTermNotesMember coty:A2023EuroNotesMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 us-gaap:LineOfCreditMember 2019-09-30 0001024305 us-gaap:BridgeLoanMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 coty:A2018CotyTermAFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 coty:A2018CotyTermBFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 coty:BankGuaranteeMember 2019-09-30 0001024305 coty:A2026DollarNotesMember us-gaap:SeniorNotesMember 2018-04-05 0001024305 us-gaap:LineOfCreditMember 2019-06-27 2019-06-27 0001024305 coty:IncurrenceIncrementalFacilitiesMember 2019-06-26 2019-06-26 0001024305 coty:TermLoanBFacilityDueOctober2022Member coty:EuroInterbankOfferedRateEuriborMember 2017-07-01 2018-06-30 0001024305 us-gaap:RevolvingCreditFacilityMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 coty:IncurrenceIncrementalFacilitiesMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 2018-04-05 0001024305 coty:IncurrenceIncrementalFacilitiesMember 2019-06-27 2019-06-27 0001024305 srt:MaximumMember us-gaap:LineOfCreditMember 2019-07-01 2019-09-30 0001024305 coty:TermLoanBFacilityDueOctober2022Member us-gaap:BaseRateMember 2017-07-01 2018-06-30 0001024305 coty:A2018CotyTermAFacilityMember 2018-04-05 0001024305 coty:SeniorUnsecuredNotesMember 2018-04-05 2018-04-05 0001024305 us-gaap:MediumTermNotesMember coty:A2018CotyTermBFacilityMember us-gaap:LineOfCreditMember 2018-09-30 2018-09-30 0001024305 coty:TermLoanBFacilityDueOctober2022Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-07-01 2018-06-30 0001024305 srt:MinimumMember us-gaap:LineOfCreditMember 2019-07-01 2019-09-30 0001024305 us-gaap:LineOfCreditMember 2019-06-27 0001024305 us-gaap:MediumTermNotesMember coty:A2018CotyTermAFacilityMember us-gaap:LineOfCreditMember 2018-09-30 2018-09-30 0001024305 coty:BankGuaranteeMember 2019-06-30 0001024305 coty:IncurrenceIncrementalFacilitiesMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 coty:A2026EuroNotesMember us-gaap:SeniorNotesMember 2018-04-05 0001024305 us-gaap:LetterOfCreditMember coty:A2018CotyRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-04-05 0001024305 us-gaap:RevolvingCreditFacilityMember coty:A2018CotyRevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-09-30 0001024305 us-gaap:MediumTermNotesMember coty:A2018CotyTermAFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 us-gaap:MediumTermNotesMember coty:A2018CotyTermBFacilityDueApril2025Member us-gaap:LineOfCreditMember 2019-09-30 0001024305 us-gaap:RevolvingCreditFacilityMember coty:A2026DollarNotesDueApril2026Member us-gaap:LineOfCreditMember 2019-09-30 0001024305 us-gaap:MediumTermNotesMember coty:A2023EuroNotesDueApril2023Member us-gaap:LineOfCreditMember 2019-09-30 0001024305 us-gaap:RevolvingCreditFacilityMember coty:A2026DollarNotesDueApril2026Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 us-gaap:MediumTermNotesMember coty:A2026EuroNotesDueApril2026Member us-gaap:LineOfCreditMember 2019-09-30 0001024305 us-gaap:MediumTermNotesMember coty:A2018CotyTermBFacilityDueApril2025Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 us-gaap:MediumTermNotesMember coty:A2026EuroNotesDueApril2026Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 us-gaap:MediumTermNotesMember coty:A2018CotyTermAFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-09-30 0001024305 us-gaap:RevolvingCreditFacilityMember coty:A2018CotyRevolvingCreditFacilityDueApril2023Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 us-gaap:MediumTermNotesMember coty:A2023EuroNotesDueApril2023Member us-gaap:LineOfCreditMember 2019-06-30 0001024305 coty:PricingTierOneMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFourMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierTwoMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFiveMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierThreeMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierTwoMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierOneMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFourMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierThreeMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0001024305 us-gaap:SeniorNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001024305 us-gaap:SeniorNotesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-30 0001024305 coty:A2018CotyCreditAgreementMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001024305 coty:A2018CotyCreditAgreementMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-30 0001024305 coty:A2018CotyCreditAgreementMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001024305 us-gaap:SeniorNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001024305 coty:A2018CotyCreditAgreementMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-09-30 0001024305 us-gaap:SeniorNotesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-09-30 0001024305 coty:PricingTierTwoMember srt:MinimumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierThreeMember srt:MaximumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFiveMember srt:MaximumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFourMember srt:MinimumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierTwoMember srt:MaximumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierOneMember srt:MinimumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFiveMember srt:MinimumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierThreeMember srt:MinimumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierFourMember srt:MaximumMember 2019-07-01 2019-09-30 0001024305 coty:PricingTierSixMember srt:MaximumMember 2019-07-01 2019-09-30 0001024305 coty:PeriodEndingDecember312021ThroughMarch312022Member 2019-07-01 2019-09-30 0001024305 coty:PeriodEndingSeptember302022ThroughDecember312022Member 2019-07-01 2019-09-30 0001024305 coty:PeriodEndingJune302022ThroughSeptember302022Member 2019-07-01 2019-09-30 0001024305 coty:PeriodEndingMarch312022ThroughJune302022Member 2019-07-01 2019-09-30 0001024305 coty:PeriodEndingMarch312023ThroughJune302023Member 2019-07-01 2019-09-30 0001024305 coty:PeriodEndingJune302019ThroughDecember312021Member 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0001024305 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0001024305 us-gaap:PostemploymentRetirementBenefitsMember 2018-07-01 2018-09-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-09-30 0001024305 us-gaap:PostemploymentRetirementBenefitsMember 2019-07-01 2019-09-30 0001024305 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember 2019-06-30 0001024305 us-gaap:NetInvestmentHedgingMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:InterestRateRiskMember 2019-09-01 2019-09-30 0001024305 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember 2019-09-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:InterestRateRiskMember 2019-06-30 0001024305 us-gaap:NetInvestmentHedgingMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember 2019-09-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:InterestRateRiskMember 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0001024305 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember 2018-07-01 2018-09-30 0001024305 us-gaap:CrossCurrencyInterestRateContractMember 2018-07-01 2018-09-30 0001024305 us-gaap:CrossCurrencyInterestRateContractMember 2019-07-01 2019-09-30 0001024305 us-gaap:InterestRateSwapMember 2018-07-01 2018-09-30 0001024305 us-gaap:InterestRateSwapMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0001024305 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-07-01 2018-09-30 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-06-30 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-07-01 2018-09-30 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-07-01 2018-09-30 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-09-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2018-07-01 2018-09-30 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2018-09-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2018-07-01 2018-09-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2018-09-30 0001024305 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-09-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2018-06-30 0001024305 2019-09-09 2019-09-09 0001024305 2019-09-30 2019-09-30 0001024305 2019-08-28 2019-08-28 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-30 0001024305 us-gaap:SeriesAPreferredStockMember 2019-09-30 0001024305 us-gaap:CommonClassAMember 2019-09-30 0001024305 coty:IncrementalRepurchaseProgramMember us-gaap:CommonClassAMember 2016-02-03 0001024305 coty:RestrictedStockUnitsAndPhantomUnitsMember us-gaap:OtherNoncurrentLiabilitiesMember 2019-09-30 0001024305 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:SeriesAPreferredStockMember 2019-09-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:CommonClassAMember 2019-09-30 0001024305 coty:SeriesA1PreferredStockMember 2019-09-30 0001024305 coty:JABCosmeticsB.V.Member us-gaap:CommonClassAMember 2019-07-01 2019-09-30 0001024305 coty:RestrictedStockUnitsAndPhantomUnitsMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2019-09-30 0001024305 coty:IncrementalRepurchaseProgramMember us-gaap:CommonClassAMember 2019-09-30 0001024305 coty:IncrementalRepurchaseProgramMember us-gaap:CommonClassAMember 2019-07-01 2019-09-30 0001024305 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-07-01 2019-09-30 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2019-07-01 2019-09-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0001024305 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-01 2019-09-30 0001024305 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2019-09-30 0001024305 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001024305 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-30 0001024305 coty:AccumulatedForeignCurrencyAdjustmentGainLossonNetInvestmentHedgeAttributabletoParentMember 2019-06-30 0001024305 coty:RestrictedAndOtherShareAwardsMember 2019-07-01 2019-09-30 0001024305 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0001024305 coty:NonQualifiedOptionsMember 2018-07-01 2018-09-30 0001024305 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0001024305 us-gaap:EmployeeStockOptionMember 2019-09-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2019-07-01 2019-09-30 0001024305 coty:RestrictedAndOtherShareAwardsMember 2019-09-30 0001024305 coty:SeriesAAndA1PreferredStockMember 2019-09-30 0001024305 us-gaap:SeriesAPreferredStockMember 2019-07-01 2019-09-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0001024305 coty:SeriesA1PreferredStockMember 2019-07-01 2019-09-30 0001024305 us-gaap:SeriesAPreferredStockMember 2018-07-01 2018-09-30 0001024305 coty:SeriesAAndA1PreferredStockMember 2019-07-01 2019-09-30 0001024305 coty:NonQualifiedOptionsMember 2019-07-01 2019-09-30 0001024305 coty:EquityPlanMember 2018-07-01 2018-09-30 0001024305 coty:FringeMember 2019-07-01 2019-09-30 0001024305 coty:FringeMember 2018-07-01 2018-09-30 0001024305 coty:EquityPlanMember 2019-07-01 2019-09-30 0001024305 us-gaap:RestrictedStockUnitsRSUMember 2019-07-01 2019-09-30 0001024305 coty:OutstandingStockOptionsSeriesAAndA1PreferredStockMember 2019-07-01 2019-09-30 0001024305 coty:YouniqueLLCMember 2019-09-30 0001024305 coty:UnitedArabEmiratesSubsidiaryMember 2019-09-30 0001024305 coty:UnitedArabEmiratesJointVentureMember us-gaap:OtherNoncurrentLiabilitiesMember 2019-06-30 0001024305 coty:UnitedArabEmiratesJointVentureMember 2019-06-30 0001024305 coty:FoundationLLCMember 2019-09-16 2019-09-16 0001024305 coty:UnitedArabEmiratesJointVentureMember us-gaap:OtherNoncurrentLiabilitiesMember 2019-09-30 0001024305 coty:SoutheasternAsianSubsidiaryMember 2019-07-01 2019-07-31 0001024305 coty:UnitedArabEmiratesJointVentureMember 2019-09-30 0001024305 coty:YouniqueLLCMember 2019-09-16 0001024305 coty:MiddleEastSubsidiaryMember 2019-06-30 0001024305 coty:UnitedArabEmiratesJointVentureMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2019-09-30 0001024305 coty:MiddleEastSubsidiaryMember 2019-09-30 0001024305 coty:UnitedArabEmiratesJointVentureMember 2019-09-30 0001024305 coty:UnitedArabEmiratesJointVentureMember coty:AccruedExpensesAndOtherCurrentLiabilitiesMember 2019-06-30 0001024305 coty:FoundationLLCMember 2019-09-16 0001024305 coty:SoutheasternAsianSubsidiaryMember 2019-09-30 0001024305 coty:YouniqueLLCMember 2019-06-30 0001024305 coty:BrazilianTaxAssessmentsMember 2019-09-30 0001024305 coty:ShareholderClassActionLawsuitsMember us-gaap:PendingLitigationMember 2019-04-09 0001024305 us-gaap:SubsequentEventMember 2019-11-06 0001024305 us-gaap:SubsequentEventMember 2019-11-06 2019-11-06 coty:business coty:segment iso4217:EUR xbrli:shares iso4217:USD xbrli:shares iso4217:USD xbrli:pure coty:class coty:vote coty:lawsuit iso4217:BRL coty:quarter
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED
SEPTEMBER 30, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM                    TO          
COMMISSION FILE NUMBER
001-35964
 
 
 
COTY INC.
(Exact name of registrant as specified in its charter)
Delaware
 
13-3823358
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
 
350 Fifth Avenue,
 
 
 New York,
NY
 
10118
(Address of principal executive offices)
 
(Zip Code)
(212) 389-7300
Registrant’s telephone number, including area code
 
 
 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes ý      No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes ý      No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
 
Accelerated filer
 
Non-accelerated filer   
 
Smaller reporting company
 
 
 
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes      No ý
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.01 par value
COTY
New York Stock Exchange
At October 30, 2019, 757,891,956 shares of the registrant’s Class A Common Stock, $0.01 par value, were outstanding.
 



COTY INC.
INDEX TO FORM 10-Q
 
 
Page
 
1
 
1
 
2
 
3
 
4
 
6
 
7
28
44
45
 
 
 
 
45
46
46
47
 
 
 
48


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share data)
(Unaudited)
 
Three Months Ended
September 30,
 
2019
 
2018
Net revenues
$
1,942.8

 
$
2,031.3

Cost of sales
738.4

 
809.1

Gross profit
1,204.4

 
1,222.2

Selling, general and administrative expenses
1,072.6

 
1,122.3

Gain on sale of business (See Note 5)
(84.5
)
 

Amortization expense
84.3

 
92.5

Restructuring costs
6.0

 
15.5

Asset impairment charges

 
12.6

Operating income (loss)
126.0

 
(20.7
)
Interest expense, net
77.4

 
64.1

Other expense, net
2.2

 
2.7

Income (loss) before income taxes
46.4

 
(87.5
)
Benefit for income taxes
(9.9
)
 
(77.4
)
Net income (loss)
56.3

 
(10.1
)
Net income attributable to noncontrolling interests
2.8

 
1.2

Net income attributable to redeemable noncontrolling interests
1.2

 
0.8

Net income (loss) attributable to Coty Inc.
$
52.3

 
$
(12.1
)
Net income (loss) attributable to Coty Inc. per common share:
 

 
 

Basic
$
0.07

 
$
(0.02
)
Diluted
0.07

 
(0.02
)
Weighted-average common shares outstanding:
 

 
 

Basic
754.2

 
750.8

Diluted
758.9

 
750.8


See notes to Condensed Consolidated Financial Statements.


1

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In millions)
(Unaudited)
 
Three Months Ended
September 30,
 
2019
 
2018
Net income (loss)
$
56.3

 
$
(10.1
)
Other comprehensive (loss) income:
 

 
 

Foreign currency translation adjustment
(122.6
)
 
(48.9
)
Net unrealized derivative (loss) gain on cash flow hedges, net of taxes of $0.2 and $(0.3), during the three months ended, respectively
(1.2
)
 
1.0

Pension and other post-employment benefits adjustment, net of tax of $0.0 and $0.5 during the three months ended, respectively
(0.8
)
 
0.1

Total other comprehensive loss, net of tax
(124.6
)
 
(47.8
)
Comprehensive loss
(68.3
)
 
(57.9
)
Comprehensive income (loss) attributable to noncontrolling interests:
 

 
 

Net income
2.8

 
1.2

Foreign currency translation adjustment

 
0.2

Total comprehensive income attributable to noncontrolling interests
2.8

 
1.4

Comprehensive income attributable to redeemable noncontrolling interests:
 
 
 
Net income
1.2

 
0.8

Comprehensive loss attributable to Coty Inc.
$
(72.3
)
 
$
(60.1
)

See notes to Condensed Consolidated Financial Statements.

2

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except per share data)
(Unaudited)
 
September 30,
2019
 
June 30,
2019
ASSETS
 

 
 

Current assets:
 

 
 

Cash and cash equivalents
$
350.4

 
$
340.4

Restricted cash
31.0

 
40.0

Trade receivables—less allowances of $55.3 and $48.1, respectively
1,036.6

 
1,161.2

Inventories
1,150.8

 
1,153.3

Prepaid expenses and other current assets
563.9

 
577.8

Total current assets
3,132.7

 
3,272.7

Property and equipment, net
1,469.9

 
1,600.6

Goodwill
4,917.3

 
5,073.8

Other intangible assets, net
6,963.8

 
7,422.3

Operating lease right-of-use assets (See Note 3)
491.9

 

Deferred income taxes
156.0

 
146.3

Other noncurrent assets
151.9

 
149.7

TOTAL ASSETS
$
17,283.5

 
$
17,665.4

LIABILITIES AND EQUITY
 

 
 

Current liabilities:


 


Accounts payable
$
1,548.1

 
$
1,732.7

Accrued expenses and other current liabilities
1,343.7

 
1,483.7

Short-term debt and current portion of long-term debt
185.4

 
193.8

Current operating lease liabilities (See Note 3)
96.5

 

Income and other taxes payable
63.7

 
66.9

Total current liabilities
3,237.4

 
3,477.1

Long-term debt, net
7,453.5

 
7,469.9

Long-term operating lease liabilities (See Note 3)
457.9

 

Pension and other post-employment benefits
570.0

 
593.5

Deferred income taxes
630.9

 
652.5

Other noncurrent liabilities
374.9

 
427.2

Total liabilities
12,724.6

 
12,620.2

COMMITMENTS AND CONTINGENCIES (See Note 17)


 


REDEEMABLE NONCONTROLLING INTERESTS
94.6

 
451.8

EQUITY:
 

 
 

Preferred Stock, $0.01 par value; 20.0 shares authorized, 9.4 and 9.4 issued and outstanding, respectively, at September 30, 2019 and June 30, 2019
0.1

 
0.1

Class A Common Stock, $0.01 par value; 1,000.0 shares authorized, 822.5 and 819.2 issued and 757.0 and 754.2 outstanding, respectively, at September 30, 2019 and June 30, 2019
8.1

 
8.1

Additional paid-in capital
10,566.1

 
10,620.5

Accumulated deficit
(4,489.6
)
 
(4,541.2
)
Accumulated other comprehensive income
(183.4
)
 
(58.8
)
Treasury stock—at cost, shares: 65.5 and 65.0, respectively, at September 30, 2019 and June 30, 2019
(1,446.3
)
 
(1,441.8
)
Total Coty Inc. stockholders’ equity
4,455.0

 
4,586.9

Noncontrolling interests
9.3

 
6.5

Total equity
4,464.3

 
4,593.4

TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
$
17,283.5

 
$
17,665.4

See notes to Condensed Consolidated Financial Statements.

3

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY AND
REDEEMABLE NONCONTROLLING INTERESTS
For the Three Months Ended September 30, 2019
(In millions, except per share data)
(Unaudited)
 
Preferred Stock
 
Class A
Common Stock
 
Additional
Paid-in Capital
 
(Accumulated Deficit)
 
Accumulated Other Comprehensive (Loss) Income
 
Treasury Stock
 
Total Coty Inc.
Stockholders’ Equity
 
Noncontrolling Interests
 
Total Equity
 
Redeemable
Noncontrolling Interests
 
Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
Shares
 
Amount
 
 
 
 
BALANCE as previously reported—July 1, 2019
9.4

 
$
0.1

 
819.2

 
$
8.1

 
$
10,620.5

 
$
(4,541.2
)
 
$
(58.8
)
 
65.0

 
$
(1,441.8
)
 
$
4,586.9

 
$
6.5

 
$
4,593.4

 
$
451.8

Adjustment due to the adoption of ASC 842 (See Note 2)
 
 
 
 
 
 
 
 
 
 
(0.7
)
 
 
 
 
 
 
 
(0.7
)
 
 
 
(0.7
)
 
 
BALANCE as adjusted—July 1, 2019
9.4

 
$
0.1

 
819.2

 
$
8.1

 
$
10,620.5

 
$
(4,541.9
)
 
$
(58.8
)
 
65.0

 
$
(1,441.8
)
 
$
4,586.2

 
$
6.5

 
$
4,592.7

 
$
451.8

Purchase of Class A Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.5

 
(4.5
)
 
(4.5
)
 
 
 
(4.5
)
 
 
Exercise of employee stock options and restricted stock units
 
 
 
 
0.1

 


 
0.6

 
 
 
 
 
 
 
 
 
0.6

 
 
 
0.6

 
 
Share-based compensation expense
 
 
 
 
 
 
 
 
6.2

 
 
 
 
 
 
 
 
 
6.2

 
 
 
6.2

 
 
Dividends declared - Cash and Other ($0.125 per common share)
 
 
 
 
 
 
 
 
(63.5
)
 
 
 
 
 
 
 
 
 
(63.5
)
 
 
 
(63.5
)
 
 
Dividends declared - Stock ($0.125 per common share)
 
 
 
 
 
 
 
 
(30.9
)
 
 
 
 
 
 
 
 
 
(30.9
)
 
 
 
(30.9
)
 
 
Dividends settled in Shares of Class A Common Stock
 
 
 
 
3.2

 


 
30.9

 
 
 
 
 
 
 
 
 
30.9

 
 
 
30.9

 
 
Net income (loss)
 
 
 
 
 
 
 
 
 
 
52.3

 
 
 
 
 
 
 
52.3

 
2.8

 
55.1

 
1.2

Other comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
(124.6
)
 
 
 
 
 
(124.6
)
 


 
(124.6
)
 


Distribution to noncontrolling interests, net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 
(1.9
)
Adjustments related to the sale of business
 
 
 
 
 
 
 
 
6.2

 
 
 
 
 
 
 
 
 
6.2

 
 
 
6.2

 
(360.4
)
Adjustment of redeemable noncontrolling interests to redemption value
 
 
 
 
 
 
 
 
(3.9
)
 
 
 
 
 
 
 
 
 
(3.9
)
 
 
 
(3.9
)
 
3.9

BALANCE—September 30, 2019
9.4

 
$
0.1

 
822.5

 
$
8.1

 
$
10,566.1

 
$
(4,489.6
)
 
$
(183.4
)
 
65.5

 
$
(1,446.3
)
 
$
4,455.0

 
$
9.3

 
$
4,464.3

 
$
94.6


See notes to Condensed Consolidated Financial Statements.

4

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY AND
REDEEMABLE NONCONTROLLING INTERESTS
For the Three Months Ended September 30, 2018
(In millions, except per share data)
(Unaudited)
 
Preferred Stock
 
Class A
Common Stock
 
Additional
Paid-in Capital
 
(Accumulated Deficit)
 
Accumulated Other Comprehensive Income (Loss)
 
Treasury Stock
 
Total Coty Inc.
Stockholders’ Equity
 
Noncontrolling Interests
 
Total Equity
 
Redeemable
Noncontrolling Interests
 
Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
Shares
 
Amount
 
 
 
 
BALANCE as previously reported—July 1, 2018
5.0

 
$

 
815.8

 
$
8.1

 
$
10,750.8

 
$
(626.2
)
 
$
158.8

 
65.0

 
$
(1,441.8
)
 
$
8,849.7

 
$
5.5

 
$
8,855.2

 
$
661.3

Adjustment due to the adoption of ASU No. 2016-16
 
 
 
 
 
 
 
 
 
 
(112.6
)
 
 
 
 
 
 
 
(112.6
)
 
 
 
(112.6
)
 
 
Adjustment due to the adoption of ASC 606
 
 
 
 
 
 
 
 
 
 
(18.2
)
 
 
 
 
 
 
 
(18.2
)
 
 
 
(18.2
)
 
 
BALANCE as adjusted—July 1, 2018
5.0

 
$

 
815.8

 
$
8.1

 
$
10,750.8

 
$
(757.0
)
 
$
158.8

 
65.0

 
$
(1,441.8
)
 
$
8,718.9

 
$
5.5

 
$
8,724.4

 
$
661.3

Exercise of employee stock options and restricted stock units
 
 
 
 

 

 
0.7

 
 
 
 
 
 
 
 
 
0.7

 
 
 
0.7

 
 
Share-based compensation expense
 
 
 
 
 
 
 
 
6.4

 
 
 
 
 
 
 
 
 
6.4

 
 
 
6.4

 
 
Dividends ($0.125 per common share)
 
 
 
 
 
 
 
 
(94.0
)
 
 
 
 
 
 
 
 
 
(94.0
)
 
 
 
(94.0
)
 
 
Net (loss) income
 
 
 
 
 
 
 
 
 
 
(12.1
)
 
 
 
 
 
 
 
(12.1
)
 
1.2

 
(10.9
)
 
0.8

Other comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
(48.0
)
 
 
 
 
 
(48.0
)
 
0.2

 
(47.8
)
 
 
Distribution to noncontrolling interests, net
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
(1.3
)
 
(1.3
)
 
(4.3
)
Additional redeemable noncontrolling interests due to employee grants (See Note 16)
 
 
 
 
 
 
 
 
(1.6
)
 
 
 
 
 
 
 
 
 
(1.6
)
 
 
 
(1.6
)
 
1.6

Adjustment of redeemable noncontrolling interests to redemption value
 
 
 
 
 
 
 
 
37.2

 
 
 
 
 
 
 
 
 
37.2

 
 
 
37.2

 
(37.2
)
BALANCE—September 30, 2018
5.0

 
$

 
815.8

 
$
8.1

 
$
10,699.5

 
$
(769.1
)
 
$
110.8

 
65.0

 
$
(1,441.8
)
 
$
8,607.5

 
$
5.6

 
$
8,613.1

 
$
622.2


See notes to Condensed Consolidated Financial Statements.

5

Table of Contents

COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)
 
Three Months Ended
September 30,
 
2019
 
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
 

 
 

Net income (loss)
$
56.3

 
$
(10.1
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 

 
 

Depreciation and amortization
179.2

 
185.6

Operating lease right-of-use asset amortization (See Note 3)
26.1

 

Deferred income taxes
(32.6
)
 
(99.8
)
Provision for bad debts
9.8

 
6.1

Provision for pension and other post-employment benefits
9.0

 
9.1

Share-based compensation
6.2

 
6.4

Gain on sale of business (See Note 5)
(84.5
)
 

Asset impairment charges

 
12.6

Other
12.4

 
11.5

Change in operating assets and liabilities, net of effects from purchase of acquired companies and sale of business:
 

 
 

Trade receivables
71.7

 
35.6

Inventories
(72.9
)
 
(109.5
)
Prepaid expenses and other current assets
(12.1
)
 
40.2

Accounts payable
(103.2
)
 
(83.2
)
Accrued expenses and other current liabilities
4.0

 
(101.3
)
Operating lease liabilities
(26.7
)
 

Income and other taxes payable
4.4

 
7.6

Other noncurrent assets
(8.2
)
 
(5.0
)
Other noncurrent liabilities
1.0

 
12.3

Net cash provided by (used in) operating activities
39.9

 
(81.9
)
CASH FLOWS FROM INVESTING ACTIVITIES:
 

 
 

Capital expenditures
(86.4
)
 
(133.6
)
Proceeds from sale of business, net of cash disposed
25.6

 

Payment for asset acquisitions

 
(40.8
)
Net cash used in investing activities
(60.8
)
 
(174.4
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 

 
 

Net repayments of short-term debt, original maturity less than three months
(3.4
)
 
(17.8
)
Proceeds from revolving loan facilities
972.6

 
771.9

Repayments of revolving loan facilities
(776.5
)
 
(239.8
)
Repayments of term loans and other long-term debt
(46.1
)
 
(48.1
)
Dividend payment
(63.3
)
 
(93.8
)
Net proceeds from issuance of Class A Common Stock and Series A Preferred Stock
0.6

 
0.7

Payments for purchases of Class A Common Stock held as Treasury Stock
(4.5
)
 

Net proceeds from (payments of) foreign currency contracts
5.3

 
(3.7
)
Purchase of remaining mandatorily redeemable noncontrolling interest
(45.0
)
 

Distributions to noncontrolling interests, redeemable noncontrolling interests and mandatorily redeemable financial instruments
(2.6
)
 
(5.6
)
Payment of debt issuance costs

 
(10.0
)
All other
(0.4
)
 
(2.0
)
Net cash provided by financing activities
36.7

 
351.8

EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH
(14.8
)
 
(4.5
)
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
1.0

 
91.0

CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period
380.4

 
362.2

CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period
$
381.4

 
$
453.2

SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
 

 
 

Cash paid during the period for interest
$
57.7

 
$
48.9

Cash received during the period for settlement of interest rate swaps

 
43.2

Cash paid during the period for income taxes, net of refunds received
39.7

 
23.9

SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING AND INVESTING ACTIVITIES:
 

 
 

Accrued capital expenditure additions
$
67.2

 
$
97.0

Non-cash Common Stock dividend
30.9

 

See notes to Condensed Consolidated Financial Statements.

6


COTY INC. & SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
($ in millions, except per share data)
(Unaudited)

1. DESCRIPTION OF BUSINESS
Coty Inc. and its subsidiaries (collectively, the “Company” or “Coty”) manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics, hair care products and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands.
The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2020” refer to the fiscal year ending June 30, 2020. When used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation.
The Company’s sales generally increase during the second fiscal quarter as a result of increased demand associated with the winter holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company’s customers may also result in variability. The Company also generally experiences an increase in sales during its fourth fiscal quarter in its Professional Beauty segment as a result of higher demand prior to the summer holiday season. See Note 18Subsequent Events for information on the Company’s turnaround plan update announced on October 21, 2019.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2019. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three months ended September 30, 2019 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2020. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
Restricted Cash
Restricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse. As of September 30, 2019 and June 30, 2019, the Company had restricted cash of $31.0 and $40.0, respectively, included in Restricted cash in the Condensed Consolidated Balance Sheets. The Restricted cash balance as of September 30, 2019 primarily provides collateral for certain bank guarantees on rent, customs and duty accounts and also consists of collections on factored receivables that remain unremitted to the factor as of September 30, 2019. Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the market value of inventory, the fair value of acquired assets and liabilities associated with acquisitions, the assessment of goodwill, other intangible assets and long-lived assets for impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates

7


and assumptions resulting from continuing changes in the economic environment will be reflected in the Condensed Consolidated Financial Statements in future periods.
Tax Information
The effective income tax rate for the three months ended September 30, 2019 and 2018 was (21.3)% and 88.5%, respectively. The negative effective tax rate in the three months ended September 30, 2019 results from reporting income before taxes and a benefit for income taxes. The positive effective tax rate in the three months ended September 30, 2018 results from reporting losses before income taxes and a benefit for income taxes. The change in the effective tax rate for the three months ended September 30, 2019, as compared to the three months ended September 30, 2018, is primarily due to the U.S. GAAP treatment of the Younique disposition in the current period and a $30.0 favorable Swiss tax ruling in the prior period.
The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes.
As of September 30, 2019 and June 30, 2019, the gross amount of UTBs was $340.3 and $336.1, respectively. As of September 30, 2019, the total amount of UTBs that, if recognized, would impact the effective income tax rate is $165.3. As of September 30, 2019 and June 30, 2019, the liability associated with UTBs, including accrued interest and penalties, was $184.0 and $179.9, respectively, which was recorded in Income and other taxes payable and Other non-current liabilities in the Condensed Consolidated Balance Sheets. The total interest and penalties recorded in the Condensed Consolidated Statements of Operations related to UTBs was $1.4 and $1.2 for the three months ended September 30, 2019 and 2018, respectively. The total gross accrued interest and penalties recorded in the Condensed Consolidated Balance Sheets as of September 30, 2019 and June 30, 2019 was $18.7 and $17.3, respectively. On the basis of the information available as of September 30, 2019, it is reasonably possible that a decrease of up to $12.9 in UTBs may occur within 12 months as a result of projected resolutions of global tax examinations and a potential lapse of the applicable statutes of limitations.
Factoring of Receivables
On September 25, 2019, the Company entered into a factoring agreement with a financial institution, which allows for the transfer of receivables from certain European Coty subsidiaries, in exchange for cash (the “European Receivables Purchase Agreement”). The total outstanding amount permitted among such subsidiaries is €93.0 million. Eligible trade receivables are purchased by the financial institution for cash at net invoice value less a factoring fee. Pursuant to the European Receivables Purchase Agreement, the Company acts as collections agent for the financial institution and is responsible for the collection, and remittance to the financial institution, of all customer payments related to trade receivables factored under this arrangement. Factoring of such receivables under the European Receivables Purchase Agreement is executed on a non-recourse basis.
The Company accounts for trade receivable transfers under the European Receivables Purchase Agreement as sales and derecognizes the sold receivables from the Condensed Consolidated Balance Sheets. The fair value of sold receivables approximated their book value due to their short-term nature. The Company estimated that the fair value of its servicing responsibilities was not material. Cash received from the selling of receivables under the European Receivables Purchase Agreement are presented as a change in trade receivables within the operating activities section of the Condensed Consolidated Statements of Cash Flows.
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lease assets and liabilities to be recorded on the balance sheet. The Company adopted this ASU and related amendments as of July 1, 2019 using the modified retrospective method. Under this approach, prior periods were not restated. Rather, lease balances and other disclosures for prior periods were provided in the notes to the financial statements as previously reported, and the cumulative effect of initially applying the guidance was recognized in the Condensed Consolidated Balance Sheets. The adoption resulted in a cumulative-effect adjustment to retained earnings of approximately $0.7.
The new leasing standard includes several optional practical expedients available that entities may elect to apply upon transition. These practical expedients relate to the identification and classification of leases that commenced before the effective date, initial direct costs for leases that commenced before the effective date, and the ability to use hindsight in evaluating lessee options to extend or terminate a lease or to purchase the underlying asset. The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which allows a lessee to carry forward its population of existing leases, the classification of each lease, as well as the treatment of initial direct costs as of the period of adoption. In addition, the Company elected the practical expedient related to lease and non-lease components, as an accounting policy election for all asset classes, which allows a lessee to not separate non-lease from lease components and instead account for consideration paid in a contract as a single lease component. Lastly, the Company did not elect the practical expedient

8


related to hindsight analysis which allows a lessee to use hindsight in determining the lease term and in assessing impairment of the entity’s right-of-use (“ROU”) assets.
The Company has made a policy election to not recognize ROU assets and lease liabilities that arise from leases with an initial term of twelve months or less on the Condensed Consolidated Balance Sheets. However, the Company will recognize these lease payments in the Condensed Consolidated Statements of Operations on a straight-line basis over the lease term and variable lease payments in the period in which the obligation is incurred. The Company has chosen to apply this accounting policy across all classes of underlying assets. Additionally, upon adoption, the Company utilized a discount rate to determine the present value of the lease payments based on information available as of July 1, 2019.
On July 1, 2019, the Company recognized a lease liability of $617.8 and a corresponding ROU asset of $551.3, including the reclassification of approximately $66.4 of unamortized lease incentives and lease loss liabilities, upon the adoption of this standard, with minimal impact on the Condensed Consolidated Statements of Operations.
See Note 3 for further information related to Leases.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which provided guidance for improvements to accounting for hedging activities under ASC 815. The amendments better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. The Company adopted the standard in the first quarter of fiscal 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
In October 2018, the FASB issued ASU No. 2018-16, Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes, which permitted the use of the OIS rate based on SOFR as a benchmark interest rate for hedge accounting purposes. The Company adopted the standard concurrently with the adoption of ASU No. 2017-12 in the first quarter of fiscal 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
Recently Issued Accounting Pronouncements
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU No. 2016-13”), which requires that a financial asset (or a group of financial assets) measured at an amortized cost basis be presented at the net amount expected to be collected. This approach to estimating credit losses applies to most financial assets measured at amortized cost and certain other instruments, including but not limited to, trade and other receivables. In November 2018, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, which clarifies the scope of the guidance in ASU No. 2016-13. The amendment will be effective for the Company in fiscal 2021 with early adoption permitted. The Company is evaluating the impact this guidance will have on the Company’s Condensed Consolidated Financial Statements and related disclosures.
3. LEASES
A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The Company determines if an arrangement is a lease at lease inception. For operating leases entered into prior to July 1, 2019, the ROU assets and operating lease liabilities are recognized in the balance sheet based on the present value of the remaining future minimum payments over the lease term from the implementation date of the standard, July 1, 2019. For leases entered into subsequent to July 1, 2019, the operating lease ROU asset and operating lease liabilities are based on the present value of minimum payments over the lease term at the commencement date of the lease.
The Company uses discount rates to determine the present value of future lease payments. The Company uses its secured incremental borrowing rate, based on the information available for leases, including the lease term and interest rate environment in the country in which the lease exists. The lease terms used to calculate the ROU asset and lease liability may include options to extend or terminate when it is reasonably certain that the Company will exercise that option.
The Company leases office facilities under non-cancelable operating leases with terms generally ranging between 10.0 and 25.0 years. The Company utilizes these leased office facilities for use by its employees in countries in which the Company conducts its business. Leases are negotiated with third parties and, in some instances contain renewal, expansion and termination options. The Company also subleases certain office facilities to third parties when the Company no longer intends to utilize the space. None of the Company’s leases restrict the payment of dividends or the incurrence of debt or additional lease obligations, or contain significant purchase options. A portion of our real estate lease portfolio contains base rents subject to annual changes in the Consumer Price Index (“CPI”) as well as charges for operating expenses which are reimbursable to the landlord based on actual usage. Changes to the CPI and payments for such reimbursable operating expenses that are not defined

9


with a minimum rate increase are considered variable and are recognized as variable lease costs in the period in which the obligation for those payments was incurred.
As a practical expedient, the Company has elected an accounting policy not to separate non-lease components from lease components and instead, account for these components as a single lease component. The Company has made an accounting policy election not to recognize ROU assets and lease liabilities for leases that, at the commencement date, are for 12 months or less. Approximately 92% of the Company’s lease obligations are for the use of office space. All of the Company’s material leases are operating leases.
The following chart provides additional information about the Company’s operating leases for the three months ended September 30, 2019:
Lease Cost:
 
Operating lease cost
$
31.7

Short-term lease cost
0.7

Variable lease cost
12.4

Sublease income
(2.2
)
Net lease cost
$
42.6

Other information:
 
Operating cash outflows from operating leases
$
31.9

Right-of-use assets obtained in exchange for lease obligations
(25.0
)
Weighted-average remaining lease term - real estate
7.7 years

Weighted-average discount rate - real estate leases
4.07
%

Future minimum lease payments for the Company’s operating leases as of September 30, 2019 are as follows:
Fiscal Year Ending June 30,
 
2020, remaining
$
89.9

2021
103.6

2022
87.2

2023
72.4

2024
62.4

Thereafter
240.1

Total future lease payments
655.6

Less: imputed interest
(101.2
)
Total present value of lease liabilities
554.4

Current operating lease liabilities
96.5

Long-term operating lease liabilities
457.9

Total operating lease liabilities
$
554.4

 
 
Table excludes obligations for leases with original terms of 12 months or less which have not been recognized as a right-of-use asset or liability in the consolidated balance sheets.
As of September 30, 2019, the Company had additional operating real estate leases that had not yet commenced of $55.0. These operating leases will commence over the next 3 months.

10


At June 30, 2019, the aggregate future minimum rental commitments under all non-cancelable operating lease agreements were as follows:
Fiscal Year Ending June 30,
 
2020
$
122.2

2021
111.2

2022
91.3

2023
76.7

2024
67.8

Thereafter
252.3

Total
721.5

Less: sublease income
(20.1
)
Total payments
$
701.4


4. SEGMENT REPORTING
The Company’s organizational structure is category focused, putting the consumers first, by specifically targeting how and where they shop and what and why they purchase. Operating and reportable segments (referred to as “segments”) reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer as the CODM.
The Company has the following three divisions which represent its operating segments and reportable segments:
Luxury — primarily focused on prestige fragrances, premium skin care and premium color cosmetics;
Consumer Beauty — primarily focused on color cosmetics, retail hair coloring and styling products, mass fragrance, mass skin care and body care;
Professional Beauty — primarily focused on hair and nail care products for professionals.
On July 1, 2019, the Company announced its turnaround plan, which includes planned changes to the reporting structure to the CODM. As part of these reporting structure changes, management expects to move from the current organizational structure into regional commercial business units in Europe, Middle East & Africa (“EMEA”) and Americas and Asia Pacific for the combined Luxury and Consumer Beauty businesses. Such regional business units will be supported by central Luxury and Consumer Beauty marketing teams. Professional Beauty is a distinct business unit. The Company anticipates that its operating and reporting segments would change upon completion of such reporting structure changes and the related changes in the financial information provided to the CODM, which is expected to occur in the third quarter of fiscal 2020. See Note 18Subsequent Events for information on the Company’s turnaround plan update announced on October 21, 2019.
Certain revenues and shared costs and the results of corporate initiatives are managed outside of the three segments by Corporate. The items within Corporate relate to corporate-based responsibilities and decisions and are not used by the CODM to measure the underlying performance of the segments. Corporate primarily includes restructuring and realignment costs, costs related to acquisition activities and certain other expense items not attributable to ongoing operating activities of the segments.
With the exception of goodwill and acquired intangible assets, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill and acquired intangible assets by segment is presented in Note 8Goodwill and Other Intangible Assets, net.

11


 
Three Months Ended
September 30,
SEGMENT DATA
2019
 
2018
Net revenues:
 
 
 
Luxury
$
806.7

 
$
792.9

Consumer Beauty
716.5

 
828.8

Professional Beauty
419.6

 
409.6

Total
$
1,942.8

 
$
2,031.3

Operating income (loss):
 
 
 
Luxury
$
90.3

 
$
48.7

Consumer Beauty
(43.3
)
 
(18.6
)
Professional Beauty
24.4

 
5.0

Corporate
54.6

 
(55.8
)
Total
$
126.0

 
$
(20.7
)
Reconciliation:
 
 
 
Operating income (loss)
$
126.0

 
$
(20.7
)
Interest expense, net
77.4

 
64.1

Other expense, net
2.2

 
2.7

Income (loss) before income taxes
$
46.4

 
$
(87.5
)

Presented below are the percentage of revenues associated with the Company’s product categories:
 
Three Months Ended
September 30,
PRODUCT CATEGORY
2019
 
2018
Fragrance
42.1
%
 
40.8
%
Color Cosmetics
24.4

 
26.4

Hair Care
24.6

 
24.1

Skin & Body Care
8.9

 
8.7

Total Coty Inc.
100.0
%
 
100.0
%

5. BUSINESS COMBINATIONS AND DIVESTITURES
Business Combinations
The Company did not acquire any businesses during the three months ended September 30, 2019.
Business Divestitures
Younique
On August 27, 2019, the Company entered into a Contribution and Redemption Agreement to transfer all of its membership interest in Foundation, LLC (“Foundation”), which held the net assets of Younique, LLC (“Younique”), to an existing noncontrolling interest holder. On September 16, 2019 (the “Closing Date”) the Company completed the sale of all of its membership interest in Foundation. Consideration received at the Closing Date consisted of $50.0 cash and a secured promissory note with a face value of $27.9. The sale resulted in a pre-tax gain of $84.5, included in Gain on sale of business in the Condensed Consolidated Statements of Operations for the three months ended September 30, 2019. Younique’s operations are included within the Consumer Beauty segment and its results of operations through the Closing Date are included in the Condensed Consolidated Statements of Operations for the three months ended September 30, 2019.
Other Transactions
Southeast Asian subsidiary
In July 2019, the Company purchased the remaining 49% noncontrolling interest in a certain consolidated Southeast Asian subsidiary. Refer to Note 16Mandatorily Redeemable Financial Interests and Redeemable Noncontrolling Interests.


12


6. RESTRUCTURING COSTS
Restructuring costs for the three months ended September 30, 2019 and 2018 are presented below:
 
Three Months Ended
September 30,
 
2019
 
2018
Turnaround Plan
$
8.7

 
$

Global Integration Activities
(1.7
)
 
6.5

2018 Restructuring Actions
(0.8
)
 
9.1

Other Restructuring
(0.2
)
 
(0.1
)
Total
$
6.0

 
$
15.5


Turnaround Plan
In connection with the four-year plan announced on July 1, 2019 to drive substantial improvement in Consumer Beauty while further optimizing Luxury and Professional Beauty (the “Turnaround Plan”), the Company has and expects to continue to incur restructuring and related costs.
Of the expected costs, the Company has incurred cumulative restructuring charges of $8.7 related to approved initiatives through September 30, 2019, which have been recorded in Corporate. The following table presents aggregate restructuring charges for the program:
 
Severance and Employee Benefits
 
Third-Party Contract Terminations
 
Fixed Asset Write-offs
 
Other Exit Costs
 
Total
Cumulative through September 30, 2019
$
7.1

 
$
0.1

 
$
0.1

 
$
1.4

 
$
8.7


Over the next four fiscal years, the Company expects to incur approximately $30.0 of additional restructuring charges pertaining to the approved actions, primarily related to employee termination benefits, fixed asset write-offs and other exit-related costs.
The related liability balance and activity for the Turnaround Plan restructuring costs are presented below:
 
Severance and Employee Benefits
 
Third-Party Contract Terminations
 
Fixed Asset Write-offs
 
Other Exit Costs
 
Total
Balance—July 1, 2019
$

 
$

 
$

 
$

 
$

Restructuring charges
7.1

 
0.1

 
0.1

 
1.4

 
8.7

Payments
(0.6
)
 

 

 

 
(0.6
)
Non-cash utilization

 

 
(0.1
)
 

 
(0.1
)
ASC 842 adoption adjustment

 

 

 
(1.4
)
 
(1.4
)
Balance—September 30, 2019
$
6.5

 
$
0.1

 
$

 
$

 
$
6.6

The Company currently estimates that the total remaining accrual of $6.6 will result in cash expenditures of approximately $5.3, $1.1 and $0.2 in fiscal 2020, 2021 and thereafter, respectively.
Global Integration Activities
In connection with the acquisition of The Procter & Gamble Company’s beauty business, the Company has incurred restructuring and related costs aimed at integrating and optimizing the combined organization (“Global Integration Activities”).
Of the expected costs, the Company has incurred cumulative restructuring charges of $498.3 related to approved initiatives through September 30, 2019, which have been recorded in Corporate. The following table presents aggregate restructuring charges for the program:

13


 
Severance and Employee Benefits
 
Third-Party Contract Terminations
 
Fixed Asset Write-offs
 
Other Exit Costs
 
Total
Fiscal 2017
$
333.9

 
$
22.4

 
$
4.6

 
$
4.1

 
$
365.0

Fiscal 2018
67.5

 
19.3

 
14.3

 
5.4

 
106.5

Fiscal 2019
(6.0
)
 
4.5

 
27.8

 
2.2

 
28.5

Fiscal 2020
(1.7
)
 

 

 

 
(1.7
)
Cumulative through September 30, 2019
$
393.7

 
$
46.2

 
$
46.7

 
$
11.7

 
$
498.3

The related liability balance activity for the Global Integration Activities restructuring costs are presented below:
 
Severance and
Employee
Benefits
 
Third-Party
Contract
Terminations
 
Fixed Asset Write-offs
 
Other
Exit
Costs
 
Total
Program
Costs
Balance—July 1, 2019
$
53.7

 
$
11.7

 
$

 
$
1.6

 
$
67.0

ASC 842 adoption adjustment

 

 

 
(1.5
)
 
(1.5
)
Payments
(8.6
)
 
(3.1
)
 

 
(0.1
)
 
(11.8
)
Changes in estimates
(1.7
)
 

 

 

 
(1.7
)
Effect of exchange rates
(1.7
)
 
(0.1
)
 

 

 
(1.8
)
Balance—September 30, 2019
$
41.7

 
$
8.5

 
$

 
$

 
$
50.2


The Company currently estimates that the total remaining accrual of $50.2 will result in cash expenditures of approximately $32.5, $15.7 and $2.0 in fiscal 2020, 2021 and thereafter, respectively.
2018 Restructuring Actions
During fiscal 2018, the Company began evaluating initiatives to reduce fixed costs and enable further investment in the business (the “2018 Restructuring Actions”).
Of the expected costs, the Company incurred cumulative restructuring charges of $84.4 related to approved initiatives through September 30, 2019, primarily related to role eliminations in Europe and North America, which have been recorded in Corporate. The following table presents aggregate restructuring charges for the program:
 
Severance and Employee Benefits
 
Third-Party Contract Terminations
 
Fixed Asset Write-offs
 
Other Exit Costs
 
Total
Fiscal 2018
$
63.5

 
$
0.2

 
$
1.3

 
$
3.4

 
$
68.4

Fiscal 2019
15.4

 
(0.1
)
 

 
1.5

 
16.8

Fiscal 2020
(0.8
)
 

 

 

 
(0.8
)
Cumulative through September 30, 2019
$
78.1

 
$
0.1

 
$
1.3

 
$
4.9

 
$
84.4


The related liability balance and activity of restructuring costs for the 2018 Restructuring Actions are presented below:
 
Severance and
Employee
Benefits
 
Third-Party
Contract
Terminations
 
Other Exit Costs
 
Total
Program
Costs
Balance—July 1, 2019
$
15.5

 
$
0.1

 
$
1.5

 
$
17.1

Payments
(2.6
)
 
(0.1
)
 

 
(2.7
)
Changes in estimates
(0.8
)
 

 

 
(0.8
)
ASC 842 adoption adjustment

 

 
(1.1
)
 
(1.1
)
Effect of exchange rates
(0.3
)
 

 

 
(0.3
)
Balance—September 30, 2019
$
11.8

 
$

 
$
0.4

 
$
12.2


The Company currently estimates that the total remaining accrual of $12.2 will result in cash expenditures of approximately $10.9, $0.9 and $0.4 in fiscal 2020, 2021 and thereafter, respectively.

14


Other Restructuring
The Company executed a number of other legacy restructuring activities in prior years, which are substantially completed. The Company recognized (income) expenses, net, of $(0.2) and $(0.1) during the three months ended September 30, 2019 and 2018, respectively. The related liability balances were $4.2 and $9.0 at September 30, 2019 and June 30, 2019, respectively. The Company currently estimates that the total remaining accrual of $4.2 will result in cash expenditures of $2.0, $1.9 and $0.3 in fiscal 2020, 2021 and 2022, respectively.
7. INVENTORIES
Inventories as of September 30, 2019 and June 30, 2019 are presented below:
 
September 30,
2019
 
June 30,
2019
Raw materials
$
252.2

 
$
259.5

Work-in-process
13.0

 
20.4

Finished goods
885.6

 
873.4

Total inventories
$
1,150.8

 
$
1,153.3


8. GOODWILL AND OTHER INTANGIBLE ASSETS, NET
Goodwill
Goodwill as of September 30, 2019 and June 30, 2019 is presented below:
 
Luxury
 
Consumer Beauty
 
Professional Beauty
 
Total
Gross balance at June 30, 2019
$
3,325.4

 
$
4,844.6

 
$
935.7

 
$
9,105.7

Accumulated impairments
(403.7
)
 
(3,628.2
)
 

 
(4,031.9
)
Net balance at June 30, 2019
$
2,921.7

 
$
1,216.4

 
$
935.7

 
$
5,073.8

 
 
 
 
 
 
 
 
Changes during the period ended September 30, 2019:
 
 
 
 
 
 
 
Disposition of business
$

 
$
(23.4
)
 
$

 
$
(23.4
)
Foreign currency translation
(67.0
)
 
(42.5
)
 
(23.6
)
 
(133.1
)
 
 
 
 
 
 
 
 
Gross balance at September 30, 2019
$
3,258.4

 
$
4,778.7

 
$
912.1

 
$
8,949.2

Accumulated impairments
(403.7
)
 
(3,628.2
)
 

 
(4,031.9
)
Net balance at September 30, 2019
$
2,854.7

 
$
1,150.5

 
$
912.1

 
$
4,917.3



Other Intangible Assets, net
Other intangible assets, net as of September 30, 2019 and June 30, 2019 are presented below:
 
September 30,
2019
 
June 30,
2019
Indefinite-lived other intangible assets
$
2,702.5

 
$
2,729.8

Finite-lived other intangible assets, net
4,261.3

 
4,692.5

Total Other intangible assets, net
$
6,963.8

 
$
7,422.3

            


15



The changes in the carrying amount of indefinite-lived other intangible assets are presented below:
 
Luxury
 
Consumer Beauty
 
Professional Beauty
 
Total
Gross balance at June 30, 2019
$
405.8

 
$
1,693.1

 
$
1,257.8

 
$
3,356.7

Accumulated impairments
(228.4
)
 
(368.4
)
 
(30.1
)
 
(626.9
)
Net balance at June 30, 2019
$
177.4

 
$
1,324.7

 
$
1,227.7

 
$
2,729.8

 
 
 
 
 
 
 
 
Changes during the period ended September 30, 2019:
 
 
 
 
 
 
 
Foreign currency translation
$
(6.7
)
 
$
(11.3
)
 
$
(9.3
)
 
$
(27.3
)
 
 
 
 
 
 
 
 
Gross balance at September 30, 2019
$
399.1

 
$
1,681.8

 
$
1,248.5

 
$
3,329.4

Accumulated impairments
(228.4
)
 
(368.4
)
 
(30.1
)
 
(626.9
)
Net balance at September 30, 2019
$
170.7

 
$
1,313.4

 
$
1,218.4

 
$
2,702.5


Intangible assets subject to amortization are presented below:
 
Cost
 
Accumulated Amortization
 
Accumulated Impairment
 
Net
June 30, 2019
 
 
 
 
 
 
 
License agreements
$
3,245.3

 
$
(874.5
)
 
$
(19.6
)
 
$
2,351.2

Customer relationships
1,951.6

 
(642.0
)
 
(5.5
)
 
1,304.1

Trademarks
1,039.5

 
(229.4
)
 
(0.5
)
 
809.6

Product formulations and technology
354.1

 
(126.5
)
 

 
227.6

Total
$
6,590.5

 
$
(1,872.4
)
 
$
(25.6
)
 
$
4,692.5

September 30, 2019
 
 
 
 
 
 
 
License agreements
$
3,147.0

 
$
(893.3
)
 
$
(19.6
)
 
$
2,234.1

Customer relationships
1,720.4

 
(590.0
)
 
(5.5
)
 
1,124.9

Trademarks
911.7

 
(222.7
)
 
(0.5
)
 
688.5

Product formulations and technology
343.9

 
(130.1
)
 

 
213.8

Total
$
6,123.0

 
$
(1,836.1
)
 
$
(25.6
)
 
$
4,261.3


In July 2018, the Company acquired a trademark associated with a preexisting license. As a result of the acquisition, the preexisting license was effectively terminated, and accordingly the Company recorded $12.6 of Asset impairment charges in the Condensed Consolidated Statement of Operations related to the license agreement.
In September 2019, the Company divested all of its membership interest in Foundation, which holds the net assets of Younique (including goodwill of $23.4 and other intangible assets of $228.6). Refer to Note 5Business Combinations and Divestitures.
Amortization expense was $84.3 and $92.5 for the three months ended September 30, 2019 and 2018, respectively.

16


9. DEBT
The Company’s debt balances consisted of the following as of September 30, 2019 and June 30, 2019, respectively:
 
September 30, 2019
 
June 30,
2019
Short-term debt
$
0.7

 
$
4.2

2018 Coty Credit Agreement
 
 
 
2018 Coty Revolving Credit Facility due April 2023
966.2

 
792.1

2018 Coty Term A Facility due April 2023
3,023.6

 
3,147.0

2018 Coty Term B Facility due April 2025
2,300.3

 
2,342.3

Senior Unsecured Notes
 
 
 
2026 Dollar Notes due April 2026
550.0

 
550.0

2023 Euro Notes due April 2023
601.4

 
625.0

2026 Euro Notes due April 2026
273.4

 
284.1

Other long-term debt and capital lease obligations
0.9

 
1.1

Total debt
7,716.5

 
7,745.8

Less: Short-term debt and current portion of long-term debt
(185.4
)
 
(193.8
)
Total Long-term debt
7,531.1

 
7,552.0

Less: Unamortized debt issuance costs
(67.2
)
 
(71.3
)
Less: Discount on Long-term debt
(10.4
)
 
(10.8
)
Total Long-term debt, net
$
7,453.5

 
$
7,469.9


Short-Term Debt
The Company maintains short-term lines of credit and other short-term debt with financial institutions around the world. As of September 30, 2019, total short-term debt decreased to $0.7 from $4.2 as of June 30, 2019. In addition, the Company had undrawn letters of credit of $5.0 and $6.3 and bank guarantees of $51.8 and $97.1 as of September 30, 2019 and June 30, 2019, respectively.
Long-Term Debt
On April 5, 2018, the Company issued senior unsecured notes in a private offering and entered into a new credit agreement (the “2018 Coty Credit Agreement”). The net proceeds of the offering of the notes, together with borrowings under the 2018 Coty Credit Agreement, were used to repay in full and refinance the indebtedness outstanding under the Company’s previously existing long-term debt agreements and to pay accrued interest, related premiums, fees and expenses in connection therewith.
Offering of Senior Unsecured Notes
On April 5, 2018 the Company issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00% senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million of 4.75% senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering.
The Senior Unsecured Notes are senior unsecured debt obligations of the Company and will be pari passu in right of payment with all of the Company’s existing and future senior indebtedness (including the 2018 Coty Credit Facilities described below). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors (as later defined under “2018 Coty Credit Agreement”). The Senior Unsecured Notes are senior unsecured obligations of the Company and are effectively junior to all existing and future secured indebtedness of the Company to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness.
The 2026 Dollar Notes will mature on April 15, 2026. The 2026 Dollar Notes will bear interest at a rate of 6.50% per annum. Interest on the 2026 Dollar Notes is payable semi-annually in arrears on April 15 and October 15 of each year.
The 2023 Euro Notes will mature on April 15, 2023 and the 2026 Euro Notes will mature on April 15, 2026. The 2023 Euro Notes will bear interest at a rate of 4.00% per annum, and the 2026 Euro Notes will bear interest at a rate of 4.75% per annum. Interest on the Euro Notes is payable semi-annually in arrears on April 15 and October 15 of each year.

17


Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, the Company will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes.
The Senior Unsecured Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of all or substantially all of the Company’s assets and certain merger or consolidation transactions. The Senior Unsecured Notes also provide for customary events of default.
2018 Coty Credit Agreement
On April 5, 2018, the Company entered into the 2018 Coty Credit Agreement, which amended and restated the prior Coty Credit Agreement. The 2018 Coty Credit Agreement provides for (a) the incurrence by the Company of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the “2018 Coty Term A Facility”) and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the “2018 Coty Term B Facility”) and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the “Dutch Borrower” and, together with the Company, the “Borrowers”), of a senior secured revolving facility in an aggregate principal amount of $3,250.0 denominated in U.S. dollars, specified alternative currencies or other currencies freely convertible into U.S. dollars and readily available in the London interbank market (the “2018 Coty Revolving Credit Facility”) (the 2018 Coty Term A Facility, together with the 2018 Coty Term B Facility and the 2018 Coty Revolving Credit Facility, the “2018 Coty Credit Facilities”). Initial borrowings under the 2018 Coty Term Loan B Facility were issued at a 0.250% discount.
The 2018 Coty Credit Agreement provides that with respect to the 2018 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00.
The obligations of the Company under the 2018 Coty Credit Agreement are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the “Guarantors”) and the obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement.
On June 27, 2019, the Company entered into an amendment (“2019 Amendment”) to the 2018 Coty Credit Agreement. The 2019 Amendment modified the 2018 Coty Credit Agreement by amending the financial covenants to (i) delay until March 31, 2022 the total net leverage ratio step down from 5.25 to 5.0 (as further described in the Covenants section below), (ii) extend the applicable window for certain cost savings add-backs in the calculation of Adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) for purpose of determining the total net leverage ratio, and (iii) amend the determination of the exchange rate to be used for purposes of calculating “Total Indebtedness” (as defined in the 2018 Coty Credit Agreement) for purposes of the total net leverage ratio, and decreasing the total commitments under the revolving credit facility by $500.0 to $2,750.0.
Scheduled Amortization
The Company makes quarterly payments of 1.25% and 0.25%, of the initial aggregate principal amounts of the 2018 Coty Term A Facility and the 2018 Coty Term B Facility, respectively. The remaining balance of the initial aggregate principal amounts of the 2018 Coty Term A Facility and the 2018 Coty Term B Facility will be payable on the maturity date for each facility, respectively.
Interest
The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company’s option, either:
LIBOR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or
Alternate base rate (“ABR”) plus the applicable margin.

18


In the case of the 2018 Coty Revolving Credit Facility and the 2018 Coty Term A Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below:
Pricing Tier
 
Total Net Leverage Ratio:
 
LIBOR plus:
 
Alternative Base Rate Margin:
1.0
 
Greater than or equal to 4.75:1
 
2.000%
 
1.000%
2.0
 
Less than 4.75:1 but greater than or equal to 4.00:1
 
1.750%
 
0.750%
3.0
 
Less than 4.00:1 but greater than or equal to 2.75:1
 
1.500%
 
0.500%
4.0
 
Less than 2.75:1 but greater than or equal to 2.00:1
 
1.250%
 
0.250%
5.0
 
Less than 2.00:1 but greater than or equal to 1.50:1
 
1.125%
 
0.125%
6.0
 
Less than 1.50:1
 
1.000%
 
—%

Pricing Tier
 
Debt Ratings S&P/Moody’s:
 
LIBOR plus:
 
Alternative Base Rate Margin:
5.0
 
Less than BB+/Ba1
 
2.000%
 
1.000%
4.0
 
BB+/Ba1
 
1.750%
 
0.750%
3.0
 
BBB-/Baa3
 
1.500%
 
0.500%
2.0
 
BBB/Baa2
 
1.250%
 
0.250%
1.0
 
BBB+/Baa1 or higher
 
1.125%
 
0.125%

In the case of the USD portion of the 2018 Coty Term B Facility, the applicable margin means 2.25% per annum, in the case of LIBOR loans, and 1.25% per annum, in the case of ABR loans. In the case of the Euro portion of the 2018 Coty Term B Facility, the applicable margin means 2.50% per annum, in the case of EURIBOR loans.
In no event will LIBOR be deemed to be less than 0.00% per annum.
Fair Value of Debt
 
September 30, 2019
 
June 30, 2019
 
Carrying
Amount
 
Fair
Value
 
Carrying
Amount
 
Fair
Value
2018 Coty Credit Agreement
$
6,290.1

 
$
5,987.2

 
$
6,281.4

 
$
6,058.9

Senior Unsecured Notes
1,424.8

 
1,417.8

 
1,459.1

 
1,439.6


The Company uses the market approach to value the 2018 Coty Credit Agreement and the Senior Unsecured Notes. The Company obtains fair values from independent pricing services to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized a Level 2 in the fair value hierarchy.

19


Debt Maturities Schedule
Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding capital lease obligations as of September 30, 2019, are presented below:
Fiscal Year Ending June 30,
 
2020, remaining
138.4

2021
184.6

2022
184.6

2023
4,171.0

2024
23.3

Thereafter
3,013.0

Total
7,714.9


Covenants
The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period.
Quarterly Test Period Ending
Total Net Leverage Ratio (a) 
September 30, 2019 through December 31, 2021
5.25 to 1.00
March 31, 2022
5.00 to 1.00
June 30, 2022
4.75 to 1.00
September 30, 2022
4.50 to 1.00
December 31, 2022
4.25 to 1.00
March 31, 2023 through June 30, 2023
4.00 to 1.00
 
 
(a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted cash and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement.
In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement, as amended), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which our Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period.
As of September 30, 2019, the Company was in compliance with all covenants contained within the Debt Agreements.
10. INTEREST EXPENSE, NET
Interest expense, net for the three months ended September 30, 2019 and 2018 is presented below:
 
Three Months Ended
September 30,
 
2019
 
2018
Interest expense
$
75.5

 
$
72.4

Foreign exchange gains, net of derivative contracts
3.8

 
(3.6
)
Interest income
(1.9
)
 
(4.7
)
Total interest expense, net
$
77.4

 
$
64.1



20


11. EMPLOYEE BENEFIT PLANS
The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below:
 
Three Months Ended September 30,
 
Pension Plans
 
Other Post-
Employment Benefits
 
 
 
U.S.
 
International
 
 
Total
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$

 
$

 
$
9.5

 
$
8.2

 
$
0.5

 
$
0.3

 
$
10.0

 
$
8.5

Interest cost
0.1

 
0.2

 
2.3

 
3.3

 
0.4

 
0.5

 
2.8

 
4.0

Expected return on plan assets

 

 
(2.1
)
 
(2.1
)
 

 

 
(2.1
)
 
(2.1
)
Amortization of prior service cost (credit)

 

 
(0.2
)
 
0.1

 
(1.6
)
 
(1.5
)
 
(1.8
)
 
(1.4
)
Amortization of net (gain) loss
0.1

 
(0.2
)
 

 
0.3

 

 

 
0.1

 
0.1

Net periodic benefit cost (credit)
$
0.2

 
$

 
$
9.5

 
$
9.8

 
$
(0.7
)
 
$
(0.7
)
 
$
9.0

 
$
9.1


12. DERIVATIVE INSTRUMENTS
Foreign Exchange Risk Management
The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. The Company entered into foreign exchange forward contracts for which hedge accounting treatment has been applied which the Company anticipates realizing in the Consolidated Statements of Operations through fiscal 2020. In addition, in September 2019, the Company entered into cross-currency swap contracts in the notional amount of $550.0 and designated these cross-currency swaps as hedges of its net investment in certain foreign subsidiaries. These cross-currency swaps allow for the exchange of fixed interest payments on the agreed upon notional amounts, between the Company and the related counterparties, effectively converting the Company’s fixed rate U.S. dollar denominated debt to euro denominated debt with more favorable fixed rate interest payments over the contracts’ term. Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of each reporting period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive income (loss) (“AOCI/(L)”) until the sale or substantial liquidation of the underlying net investments.
Interest Rate Risk Management
The Company is exposed to interest rate fluctuations related to its variable rate debt instruments. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in the variable interest rates by entering into offsetting positions through the use of derivative instruments, such as interest rate swap contracts. The interest rate swap contracts result in recognizing a fixed interest rate for the portion of the Company’s variable rate debt that was hedged. This will reduce the negative and positive impacts of changes in the variable rates over the term of the contracts. Hedge effectiveness of interest rate swap contracts is based on a long-haul hypothetical derivative methodology and includes all changes in value.
During September 2019, the Company entered into incremental interest rate swap contracts in the notional amount of $1,000.0, which extended the maturity of the interest rate swap portfolio from 2021 through 2023. These interest rate swaps are designated and qualify as cash flow hedges. As of September 30, 2019 and June 30, 2019, the Company had interest rate swap contracts designated as effective hedges in the notional amount of $3,000.0 and $2,000.0, respectively.
Derivative and non-derivative financial instruments which are designated as hedging instruments:
The accumulated gain on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $372.1 and $214.8 as of September 30, 2019 and June 30, 2019, respectively.
The accumulated gain on derivative instruments classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $3.9 and $0.0 as of September 30, 2019 and June 30, 2019, respectively.


21


The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below:
Gain (Loss) Recognized in OCI
Three Months Ended
September 30,
 
2019
 
2018
Foreign exchange forward contracts
$
0.4

 
$

Interest rate swap contracts
(0.5
)
 
5.1

Cross-currency swap contracts
3.9

 

Net investment hedge
157.3

 
4.3


The accumulated gain on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $(14.5) and $(13.3) as of September 30, 2019 and June 30, 2019, respectively. The estimated net loss related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings, net of tax, within the next twelve months is $(3.9). As of September 30, 2019, all of the Company’s remaining foreign currency forward contracts designated as hedges were highly effective.
The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below:
Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships
Three Months Ended September 30,
 
2019
 
2018
 
Cost of sales
 
Interest expense, net
 
Cost of sales
 
Interest expense, net
Foreign exchange forward contracts:
 
 
 
 
 
 
 
Amount of gain (loss) reclassified from AOCI into income
$
0.2

 
$

 
$

 
$

Interest rate swap contracts:
 
 
 
 
 
 
 
Amount of gain (loss) reclassified from AOCI into income

 
0.9

 

 
3.8


Derivatives not designated as hedging:
The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below:
Condensed Consolidated Statements of Operations
Classification of Gain (Loss) Recognized in Operations
Three Months Ended
September 30,
 
 
2019
 
2018
Foreign exchange contracts
Selling, general and administrative expenses
$
(0.2
)
 
$

Foreign exchange contracts
Interest expense, net
4.7

 
4.0

Foreign exchange contracts
Other expense, net
(0.1
)
 
1.3


13. EQUITY
Common Stock
As of September 30, 2019, the Company’s common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. As of September 30, 2019, total authorized shares of Class A Common Stock was 1,000.0 million and total outstanding shares of Class A Common Stock was 757.0 million.
As of September 30, 2019, the Company’s largest stockholder was Cottage Holdco B.V., which owned approximately 60% of Coty’s Class A shares. Cottage Holdco B.V., a wholly-owned subsidiary of JABC, is indirectly controlled by Lucresca SE, Agnaten SE and JAB Holdings B.V. (“JAB”). During the three months ended September 30, 2019, JABC acquired nil shares Class A Common Stock in open market purchases on the New York Stock Exchange and elected to receive 2.8 million shares of Class A Common Stock under the Company’s dividend reinvestment program.

22


Preferred Stock
As of September 30, 2019, total authorized shares of preferred stock are 20.0 million. There are two classes of Preferred Stock outstanding as of September 30, 2019, Series A Preferred Stock and Series A-1 Preferred Stock, both with a par value of $0.01 per share.
As of September 30, 2019, total authorized, issued and outstanding shares of Series A Preferred Stock and Series A-1 Preferred Stock are 1.5 million and 7.9 million, respectively. The Series A Preferred Stock and Series A-1 Preferred Stock are not entitled to receive any dividends and have no voting rights except as required by law.
As of September 30, 2019, the Company classified $1.2 of Preferred Stock as equity, and $2.0 as a liability recorded in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet.
Treasury Stock
Share Repurchase Program
Since February 2014, the Board has authorized the Company to repurchase its Class A Common Stock under approved repurchase programs. On February 3, 2016, the Board authorized the Company to repurchase up to $500.0 of its Class A Common Stock (the “Incremental Repurchase Program”). Repurchases may be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, and general market conditions. For the three months ended September 30, 2019, the Company did not repurchase any shares of its Class A Common Stock. As of September 30, 2019, the Company had authority for $396.8 remaining under the Incremental Repurchase Program.
Other Repurchases
The Company repurchased 0.5 million shares of Common Stock for $4.5 during the three months ended September 30, 2019 in connection with the exit of an executive in September 2019.
Dividends
The following dividends were declared during the three months ended September 30, 2019:
Declaration Date
 
Dividend Type
 
Dividend Per Share
 
Holders of Record Date
 
Dividend Value
 
Dividend Payment Date
 
Dividends Settled in Cash
 
Dividends Settled in Stock (a)
 
Dividends Payable (b)
Fiscal 2020
  August 28, 2019
 
Quarterly
 
$
0.125

 
September 9, 2019
 
$
0.125

 
September 30, 2019
 
$
63.3

 
$
30.9

 
$
1.1

 
 
(a) 
The September 30, 2019 stock dividend payment of $30.9 resulted in the issuance of 3.2 million shares of Class A Common Stock.
(b) 
The dividend payable is the value of the remaining dividends payable upon settlement of the RSUs and phantom units outstanding as of the Holders of Record Date. Dividends payable are recorded as Accrued expense and other current liabilities and Other noncurrent liabilities in the Condensed Consolidated Balance Sheet.
Total dividends in cash and other recorded to additional paid-in capital (“APIC”) in the Condensed Consolidated Balance Sheet as of September 30, 2019 was $63.5, consisting of $63.3 dividends settled in cash, $1.1 dividends payable, offset by $0.9 of dividends no longer expected to vest as a result of forfeitures of outstanding RSUs.
In addition to the activity noted above, the Company made a payment of nil for the previously accrued dividends on RSUs that vested during the three months ended September 30, 2019. Thus, total dividends settled in cash during the three months ended September 30, 2019 was $63.3.
Total accrued dividends on unvested RSUs and phantom units of $3.6 and $4.0 are included in Accrued expenses and other current liabilities and Other noncurrent liabilities, respectively, in the Condensed Consolidated Balance Sheet as of September 30, 2019.

23


Accumulated Other Comprehensive Income (Loss)
 
 
 
Foreign Currency Translation Adjustments
 
 
 
 
 
Loss on Cash Flow Hedges
 
Gain on Net Investment Hedge
 
Other Foreign Currency Translation Adjustments
 
Pension and Other Post-Employment Benefit Plans (a)
 
Total
Balance—July 1, 2019
$
(13.3
)
 
$
214.8

 
$
(257.4
)
 
$
(2.9
)
 
$
(58.8
)
Other comprehensive (loss) income before reclassifications
(0.5
)
 
161.2

 
(283.8
)
 

 
(123.1
)
Net amounts reclassified from AOCI/(L)
(0.7
)
 

 

 
(0.8
)
 
(1.5
)
Net current-period other comprehensive (loss) income
(1.2
)
 
161.2

 
(283.8
)
 
(0.8
)
 
(124.6
)
Balance—September 30, 2019
$
(14.5
)
 
$
376.0

 
$
(541.2
)
 
$
(3.7
)
 
$
(183.4
)
 
 
(a) For the three months ended September 30, 2019, net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial loss of $0.8, net of tax of $0.0.
 
 
 
Foreign Currency Translation Adjustments
 
 
 
 
 
Gain on Cash Flow Hedges
 
Gain on Net Investment Hedge
 
Other Foreign Currency Translation Adjustments
 
Pension and Other Post-Employment Benefit Plans
 
Total
Balance—July 1, 2018
$
31.7

 
$
115.0

 
$
(44.3
)
 
$
56.4

 
$
158.8

Other comprehensive income (loss) before reclassifications
3.9

 
4.3

 
(53.4
)
 
0.1

 
(45.1
)
Net amounts reclassified from AOCI/(L)
(2.9
)
 

 

 

 
(2.9
)
Net current-period other comprehensive income (loss)
1.0

 
4.3

 
(53.4
)
 
0.1

 
(48.0
)
Balance—September 30, 2018
$
32.7

 
$
119.3

 
$
(97.7
)
 
$
56.5

 
$
110.8


14. SHARE-BASED COMPENSATION PLANS
Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below:
 
Three Months Ended
September 30,
 
2019
 
2018
Equity plan expense
$
6.2

 
$
6.4

Fringe expense
0.1

 

Total share-based compensation expense
$
6.3

 
$
6.4


The share-based compensation expense for the three months ended September 30, 2019 and 2018, respectively, of $6.3 and $6.4 include $8.8 and $9.3 expense offset by $2.5 and $2.9 income, respectively, primarily due to significant executive forfeitures of share-based compensation instruments.
As of September 30, 2019, the total unrecognized share-based compensation expense related to stock options, Series A and A-1 Preferred Stock and restricted and other share awards is $39.9, $8.6 and $72.3, respectively. The unrecognized share-based compensation expense related to stock options, Series A and A-1 Preferred stock and restricted and other share awards is expected to be recognized over a weighted-average period of 4.00, 4.19 and 3.28 years, respectively.

24


Restricted Share Units and Other Share Awards
The Company granted approximately nil RSUs and other share awards during the three months ended September 30, 2019. The Company recognized share-based compensation expense of $5.0 and $4.1 for the three months ended September 30, 2019 and 2018, respectively.
Series A Preferred Stock and Series A-1 Preferred Stock
The Company granted no shares of Series A Preferred Stock and no shares of Series A-1 Preferred Stock during the three months ended September 30, 2019. The Company recognized share-based compensation expense (income) of $0.5 and $(0.1) for the three months ended September 30, 2019 and 2018, respectively.
Non-Qualified Stock Options
The Company granted no non-qualified stock options during the three months ended September 30, 2019. The Company recognized share-based compensation expense of $0.8 and $2.4 for the three months ended September 30, 2019 and 2018, respectively.
15. NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC. PER COMMON SHARE
Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below:
 
Three Months Ended
September 30,
 
2019
 
2018
 
(in millions, except per share data)
Net income (loss) attributable to Coty Inc.
$
52.3

 
$
(12.1
)
Weighted-average common shares outstanding—Basic
754.2

 
750.8

Effect of dilutive stock options and Series A/A-1 Preferred Stock (a)
1.1

 

Effect of restricted stock and RSUs (b)
3.6

 

Weighted-average common shares outstanding—Diluted
758.9

 
750.8

Net income (loss) attributable to Coty Inc. per common share:
 
 
 
Basic
$
0.07

 
$
(0.02
)
Diluted
0.07

 
(0.02
)
 
 
(a) 
For the three months ended September 30, 2019, outstanding stock options and Series A/A-1 Preferred Stock with purchase or conversion rights to purchase 24.3 million shares of Common Stock were excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. For the three months ended September 30, 2018, outstanding stock options and Series A/A-1 Preferred Stock with purchase or conversion rights to purchase shares of Common Stock were excluded in the computation of diluted loss per share due to the net loss incurred during the period.
(b) 
For the three months ended September 30, 2019, there were 0.6 million anti-dilutive RSUs excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. For the three months ended September 30, 2018, RSUs were excluded in the computation of diluted loss per share due to the net loss incurred during the period.
16. MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS
Mandatorily Redeemable Financial Interest
United Arab Emirates subsidiary
The Company is required under a shareholders agreement (the “U.A.E. Shareholders Agreement”) to purchase all of the shares held by the noncontrolling interest holder equal to 25% of a certain subsidiary in the United Arab Emirates (the “U.A.E. subsidiary”) at the termination of the agreement. The Company has determined such shares to be a mandatorily redeemable financial instrument (“MRFI”) that is recorded as a liability. The liability is calculated based upon a pre-determined formula in accordance with the U.A.E. Shareholders Agreement. As of September 30, 2019 and June 30, 2019, the liability amounted to $7.1 and $7.5, of which $5.1 and $6.1, respectively, was recorded in Other noncurrent liabilities and $2.0 and $1.4, respectively, was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.

25


Southeast Asian subsidiary
In July 2019, the Company purchased the remaining 49% noncontrolling interest of a certain Southeast Asian subsidiary from the noncontrolling interest holder for $45.0, pursuant to a Sale of Shares and Termination Deed, as amended. The termination was effective on June 30, 2019 and immediately prior to the cash purchase of the remaining noncontrolling interest, the noncontrolling interest balance was recorded as a MRFI liability. As of September 30, 2019, the remaining MRFI liability of $7.2, which was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet, relates to remaining retained earnings and will be paid out as dividends by December 31, 2019.
Redeemable Noncontrolling Interests
Younique
On September 16, 2019, the Company completed the sale of all of its membership interest in Foundation, which held the net assets of Younique. On the date of this transaction, the Younique membership holders had a 40.7% membership interest in Foundation. See Note 5Business Combinations and Divestitures. As a result of the Company’s sale of its membership interest in Foundation, RNCI of $360.4 was derecognized as of the date of sale.
The Company accounted for the 40.7% noncontrolling interest portion of Foundation as redeemable noncontrolling interest (“RNCI”) due to the noncontrolling interest holder’s right to put their shares to the Company in certain circumstances. Foundation was a majority-owned consolidated subsidiary through September 16, 2019 and the Company recorded income tax expense based on the Company’s 59.3% membership interest in Foundation due to its treatment as a partnership for U.S. income tax purposes. Accordingly, Foundation’s net income attributable to RNCI is equal to the 40.7% noncontrolling interest of Foundation’s net income excluding a provision for income taxes. The Company recognized $365.3 as the RNCI balance as of June 30, 2019.
Subsidiary in the Middle East
As of September 30, 2019, the noncontrolling interest holder in the Company’s subsidiary in the Middle East (“Middle East Subsidiary”) had a 25% ownership share. The Company adjusts the RNCI to redemption value at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $94.6 and $86.5 as the RNCI balances as of September 30, 2019 and June 30, 2019, respectively.
17. COMMITMENTS AND CONTINGENCIES
Legal Matters
The Company is involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to its business, including consumer class or collective actions, personal injury (including asbestos related claims), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company’s securities. However, management’s assessment of the Company’s current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities.
Certain Litigation. Two purported stockholder class action complaints concerning the tender offer by Cottage Holdco B.V. (the “Cottage Tender Offer”) and the Schedule 14D-9 were filed by putative stockholders against the Company and the directors of the Company in the U.S. District Court for the District of Delaware, but have not yet been served. In both complaints, the plaintiffs allege that the Company’s Schedule 14D-9 omits certain information, including, among other things, certain financial data and certain analyses underlying the opinion of Centerview Partners LLC. Plaintiffs assert claims under the federal securities laws and seek, among other things, injunctive and/or monetary relief. The cases are captioned Phillips v. Coty, Inc., et al., Case No. 1:19-cv-00628-LPS and Rumsey v. Coty, Inc., et al., Case No. 1:19-cv-00650-LPS. On October 31, 2019, the plaintiffs in Phillips v. Coty voluntarily dismissed their complaint with prejudice.
A third consolidated purported stockholder class action and derivative complaint concerning the Cottage Tender Offer and the Schedule 14D-9 is pending against the directors of the Company, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. in the Court of Chancery of the State of Delaware. The Company was named as a nominal defendant. The

26


case, which was filed on May 6, 2019, was captioned Massachusetts Laborers’ Pension Fund v. Harf et.al., Case No. 2019-0336-CB. On June 14, 2019, plaintiffs in the consolidated action filed a Verified Amended Class Action and Derivative Complaint (“Amended Complaint”). After defendants responded to the Amended Complaint, on October 21, 2019, plaintiffs filed a Verified Second Amended Class Action and Derivative Complaint (the “Second Amended Complaint”), alleging that the directors and JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. breached their fiduciary duties to the Company’s stockholders and breached the Stockholders Agreement. The Second Amended Complaint seeks, among other things, monetary relief. The defendants’ responses to the Second Amended Complaint are due on November 21, 2019.
Brazilian Tax Assessments
In connection with a local tax audit of one of the Company’s subsidiaries in Brazil, the Company was notified of tax assessments issued in March 2018. The assessments relate to local sales tax credits, which the Treasury Office of the State of Goiás considers improperly registered for the 2016-2017 tax periods. The Company is currently seeking a favorable administrative decision on the tax enforcement action filed by the Treasury Office of the State of Goiás. These tax assessments, including estimated interest and penalties, through September 30, 2019 amount to a total of R$249.0 million (approximately $59.8). The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable.
18. SUBSEQUENT EVENTS
Quarterly Dividend
On November 6, 2019, the Company announced a quarterly cash dividend of $0.125 per share on its Common Stock, RSUs and phantom units. The dividend will be payable on December 27, 2019 to holders of record of Common Stock as of November 18, 2019. The shareholders will have an option to elect to receive their dividend 50% in cash and 50% in Common Stock.
Turnaround Plan Update
On October 21, 2019, the Company announced that as part of its ongoing strategic review of its business, management and the Board of Directors have determined that moving forward the Company will focus more intently on its fragrance, cosmetics and skin care businesses. As a result, Coty is launching a process to explore strategic alternatives, including divestiture, for its Professional Beauty business including associated hair brands sold by the Consumer Beauty division, as well as the Company’s Brazilian operations. The Company expects that the proceeds from any potential transaction will be used to pay down debt and return excess cash to shareholders.

27


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its consolidated subsidiaries, should be read in conjunction with the information contained in the Condensed Consolidated Financial Statements and related notes included elsewhere in this document, and in our other public filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (“Fiscal 2019 Form 10-K”). When used in this discussion, the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. Also, when used in this discussion, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. The following report includes certain non-GAAP financial measures. See “Overview—Non-GAAP Financial Measures” for a discussion of non-GAAP financial measures and how they are calculated.
All dollar amounts in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
When used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. More information about potential risks and uncertainties that could affect our business and financial results is included under the heading “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Quarterly Report on Form 10-Q and other periodic reports we have filed and may file with the SEC from time to time.
Forward Looking Statements
Certain statements in this Form 10-Q are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, the Company’s Turnaround Plan, strategic planning, targets, segment reporting and outlook for future reporting periods (including the extent and timing of revenue, expense and profit trends and changes in operating cash flows and cash flows from operating activities and investing activities), the strategic review of its Professional Beauty business, associated hair and nail brands sold by the Consumer Beauty division and Brazilian operations and any transaction related thereto (the “Strategic Review”), including timing of such Strategic Review and any transaction and the use of proceeds from any such transaction, its future operations and strategy, ongoing and future cost efficiency and restructuring initiatives and programs, strategic transactions (including their expected timing and impact), investments, licenses and portfolio changes, synergies, savings, performance, cost, timing and integration of acquisitions, future cash flows, liquidity and borrowing capacity, timing and size of cash outflows and debt deleveraging, impact and timing of supply chain disruptions and the resolution thereof, timing and extent of any future impairments, and synergies, savings, impact, cost, timing and implementation of the Company’s Turnaround Plan, including operational and organizational structure changes, segment reporting changes, operational execution and simplification initiatives, the move of the Company’s headquarters, and the priorities of senior management. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “are going to”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “temporary”, “target”, “aim”, “potential”, “goal” and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to:
our ability to successfully implement our multi-year Turnaround Plan, including our management headquarters relocation, management realignment and segment reporting changes, and to develop and achieve our global business strategies, compete effectively in the beauty industry and achieve the benefits contemplated by our strategic initiatives within the expected time frame or at all;
the result of the Strategic Review and whether such Strategic Review will result in any transactions and the amount and use of proceeds from any such transactions;
our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly, and the market acceptance of new products, including any relaunched or rebranded products and the anticipated costs and discounting associated with such relaunches and rebrands, and consumer receptiveness to our current and future marketing philosophy and consumer engagement activities (including digital marketing and media);
use of estimates and assumptions in preparing our financial statements, including with regard to revenue recognition, income taxes, the assessment of goodwill, other intangible assets and long-lived assets for impairment, the market value of inventory, and the fair value of acquired assets and liabilities associated with acquisitions;
the impact of any future impairments;
managerial, transformational, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with the Turnaround Plan, the Strategic

28

Table of Contents

Review and any related transaction, and future strategic initiatives, and, in particular, our ability to manage and execute many initiatives simultaneously including any resulting complexity, employee attrition or diversion of resources;
future acquisitions, new licenses and joint ventures and the integration thereof with our business, operations, systems, financial data and culture and the ability to realize synergies, avoid future supply chain and other business disruptions, reduce costs (including through our cash efficiency initiatives), avoid liabilities and realize potential efficiencies and benefits (including through our restructuring initiatives) at the levels and at the costs and within the time frames contemplated or at all;
increased competition, consolidation among retailers, shifts in consumers’ preferred distribution and marketing channels (including to digital and luxury channels), distribution and shelf-space resets or reductions, compression of go-to-market cycles, changes in product and marketing requirements by retailers, reductions in retailer inventory levels and order lead-times or changes in purchasing patterns, and other changes in the retail, e-commerce and wholesale environment in which we do business and sell our products and our ability to respond to such changes;
our and our business partners’ and licensors’ abilities to obtain, maintain and protect the intellectual property used in our and their respective businesses, protect our and their respective reputations (including those of our and their executives or influencers) and public goodwill, and defend claims by third parties for infringement of intellectual property rights;
any change to our capital allocation and/or cash management priorities, including any change in our stock dividend reinvestment program (the “Stock Dividend Reinvestment Program”) and policy;
any unanticipated problems, liabilities or integration or other challenges associated with a past or future acquired business which could result in increased risk or new, unanticipated or unknown liabilities, including with respect to environmental, competition and other regulatory, compliance or legal matters;
our international operations and joint ventures, including enforceability and effectiveness of our joint venture agreements and reputational, compliance, regulatory, economic and foreign political risks, including difficulties and costs associated with maintaining compliance with a broad variety of complex local and international regulations;
our dependence on certain licenses (especially in our Luxury division) and our ability to renew expiring licenses on favorable terms or at all;
our dependence on entities performing outsourced functions, including outsourcing of distribution functions, and third-party manufacturers, logistics and supply chain suppliers, and other suppliers, including third-party software providers;
administrative, product development and other difficulties in meeting the expected timing of market expansions, product launches and marketing efforts;
global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect our business, financial performance, operations or products, including the impact of Brexit, the current U.S. administration, changes in the U.S. tax code, and recent changes and future changes in tariffs, retaliatory or trade protection measures, trade policies and other international trade regulations in the U.S., the European Union and Asia and in other regions where we operate;
currency exchange rate volatility and currency devaluation;
the number, type, outcomes (by judgment, order or settlement) and costs of current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including litigation relating to the tender offer by Cottage Holdco B.V. (the “Cottage Tender Offer”);
our ability to manage seasonal factors and other variability and to anticipate future business trends and needs;
disruptions in operations, sales and in other areas, including due to disruptions in our supply chain, restructurings and other business alignment activities, the move of our headquarters to Amsterdam, implementation of the Strategic Review, manufacturing or information technology systems, labor disputes, extreme weather and natural disastersand the impact of such disruptions on our ability to generate profits, stabilize or grow revenues or cash flows, comply with our contractual obligations and accurately forecast demand and supply needs and/or future results;
restrictions imposed on us through our license agreements, credit facilities and senior unsecured bonds or other material contracts, our ability to generate cash flow to repay, refinance or recapitalize debt and otherwise comply with our debt instruments, and changes in the manner in which we finance our debt and future capital needs;

29

Table of Contents

increasing dependency on information technology and our ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, costs and timing of implementation and effectiveness of any upgrades or other changes to information technology systems, and the cost of compliance or our failure to comply with any privacy or data security laws (including the European Union General Data Protection Regulation (the “GDPR”) and the California Consumer Privacy Act) or to protect against theft of customer, employee and corporate sensitive information;
our ability to attract and retain key personnel and the impact of senior management transitions and organizational structure changes, including the co-location of key business leaders and functions in Amsterdam;
the distribution and sale by third parties of counterfeit and/or gray market versions of our products;
the impact of the Cottage Tender Offer and of our Turnaround Plan, and the Strategic Review and any related transactions, on our relationships with key customers and suppliers and certain material contracts;
our relationship with Cottage Holdco B.V., as our majority stockholder, and its affiliates, and any related conflicts of interest or litigation;
future sales of a significant number of shares by our majority stockholder or contractually by certain commercial banks on behalf of our majority stockholder, as may be required to satisfy obligations under such majority stockholder's credit agreement, or the perception that such sales could occur; and
other factors described elsewhere in this document and in documents that we file with the SEC from time to time.
All forward-looking statements made in this document are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such, and should only be viewed as historical data.
Industry, Ranking and Market Data
Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the markets in which we operate, including our general expectations about our industry, market position, market opportunity and market sizes, is based on data from various sources including internal data and estimates as well as third-party sources widely available to the public such as independent industry publications, government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third-party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management’s understanding of industry conditions, and such information has not been verified by any independent sources. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we generally believe the market, industry and other information included in this Quarterly Report on Form 10-Q to be the most recently available and to be reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.
Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2020” refer to the fiscal year ending June 30, 2020. Any reference to a year not preceded by “fiscal” refers to a calendar year.
OVERVIEW
We are one of the world’s largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, hair color and styling, and skin and body care. We are the global leader in fragrance, a strong number two in professional hair color & styling, and number three in color cosmetics. The transformational acquisition of the P&G Beauty Business and our other strategic transactions have strengthened and diversified our presence across the countries, categories and channels in which we compete, building a strong beauty platform. Our products are sold in more than 150 countries around the world.
The prestige beauty market, including luxury fragrances, remains strong and our Luxury brand portfolio continues to grow in the low to mid single digits. The mass beauty categories in which we compete, including color cosmetics, hair color, mass fragrance and body care, are declining in the low single digits. While our portfolio of Consumer Beauty brands continues to underperform the market, declining in the high single digits, we have begun to see some initial positive signals as we have begun deploying our Turnaround Plan.

30

Table of Contents

The economics of developing, producing, launching, supporting and discontinuing products impact the timing of our sales and operating performance each period. In addition, as product life cycles shorten, results are driven primarily by successfully developing, introducing and marketing new, innovative products.
Turnaround Plan Update
In July 2019, we commenced the implementation of our multi-year Turnaround Plan, which aims to stabilize and gradually accelerate revenue growth, improve our profitability through gross margin growth and cost control, and deleverage our balance sheet. In connection with the Turnaround Plan, we also announced organizational changes to reduce geographic fragmentation and costs, including the co-location of most of our executive team and corporate functions in a centralized management headquarters in Amsterdam, which is expected to host approximately 500 to 700 roles (largely impacting our London, Geneva and New York operations). These organizational changes are still being operationalized, which introduces additional complexity as we roll out several initiatives simultaneously.
While we are in the very early stages of implementing our Turnaround Plan, we believe our first quarter fiscal 2020 performance reflects some very early results, including: (i) share gains in core countries for Sally Hansen, Rimmel and Bruno Banani as we improved our brand execution and increased brand support; (ii) improvement in our gross margin partially fueled by proactive initiatives to reduce product diversion through lower priced distribution channels; (iii) significant increase in working media behind our priority Consumer Beauty brand-country combinations; and (iv) net revenue declines in these priority Consumer Beauty brand-country combinations have decelerated and have outperformed the overall division.
In addition, going forward we have decided to focus on the fragrance, color cosmetics and skin care categories, with the goal of stabilizing the Consumer Beauty business and amplifying the performance of the Luxury business. The divestiture of the Younique business and the recently announced plan to explore strategic options, including divestiture, for our Professional Beauty business and related retail hair brands as well as our Brazilian mass beauty operations, are both reflections of our intent to focus on our core go-to-market competencies and to simultaneously deleverage our balance sheet.
Non-GAAP Financial Measures
To supplement the financial measures prepared in accordance with GAAP, we use non-GAAP financial measures including Adjusted operating income, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share (collectively, the “Adjusted Performance Measures”). The reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Three Months Ended September 30, 2019 As Compared To Three Months Ended September 30, 2018.” These non-GAAP financial measures should not be considered in isolation from, or as a substitute for or superior to, financial measures reported in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of the business as determined in accordance with GAAP. Other companies, including companies in the beauty industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.
Despite the limitations of these non-GAAP financial measures, our management uses the Adjusted Performance Measures as key metrics in the evaluation of our performance, preparation of our annual budgets and to benchmark performance of our business against our competitors. The following are examples of how these Adjusted Performance Measures are utilized by our management:
strategic plans and annual budgets are prepared using the Adjusted Performance Measures;
senior management receives a monthly analysis comparing budget to actual operating results that is prepared using the Adjusted Performance Measures; and
senior management’s annual compensation is calculated, in part, by using some of the Adjusted Performance Measures.
In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these Adjusted Performance Measures.
Our management believes that Adjusted Performance Measures are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP financial measures address questions we routinely receive from analysts and investors and, in order to ensure that all investors have access to the same data, our management has determined that it is appropriate to make this data available to all investors. The Adjusted Performance Measures exclude the impact of certain items (as further described below) and provide supplemental information regarding our operating performance. By disclosing these non-GAAP financial measures, our management intends to provide investors with a supplemental comparison of our operating results and trends for the periods presented. Our management believes these

31

Table of Contents

measures are also useful to investors as such measures allow investors to evaluate our performance using the same metrics that our management uses to evaluate past performance and prospects for future performance. We provide disclosure of the effects of these non-GAAP financial measures by presenting the corresponding measure prepared in conformity with GAAP in our financial statements, and by providing a reconciliation to the corresponding GAAP measure so that investors may understand the adjustments made in arriving at the non-GAAP financial measures and use the information to perform their own analyses.
Adjusted operating income excludes restructuring costs and business structure realignment programs, amortization, acquisition-related costs and acquisition accounting impacts, asset impairment charges and other adjustments as described below. We do not consider these items to be reflective of our core operating performance due to the variability of such items from period-to-period in terms of size, nature and significance. They are primarily incurred to realign our operating structure and integrate new acquisitions, and fluctuate based on specific facts and circumstances. Additionally, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share are adjusted for certain interest and other (income) expense as described below and the related tax effects of each of the items used to derive Adjusted net income as such charges are not used by our management in assessing our operating performance period-to-period.
Adjusted Performance Measures reflect adjustments based on the following items:
Costs related to acquisition activities: We have excluded acquisition-related costs and acquisition accounting impacts such as those related to transaction costs and costs associated with the revaluation of acquired inventory in connection with business combinations because these costs are unique to each transaction. The nature and amount of such costs vary significantly based on the size and timing of the acquisitions and the maturities of the businesses being acquired. Also, the size, complexity and/or volume of past acquisitions, which often drives the magnitude of such expenses, may not be indicative of the size, complexity and/or volume of any future acquisitions.
Restructuring and other business realignment costs: We have excluded costs associated with restructuring and business structure realignment programs to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
Asset impairment charges: We have excluded the impact of asset impairments as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
Gain on sale of business: We have excluded the impact of the Gain on sale of business as such amounts are inconsistent in amount and frequency and are significantly impacted by the size of divestitures. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
Amortization expense: We have excluded the impact of amortization of finite-lived intangible assets, as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance. Although we exclude amortization of intangible assets from our non-GAAP expenses, our management believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets.;
Other expense: We have excluded the impact of costs incurred for legal and advisory services rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders. Our management believes these costs do not reflect our underlying ongoing business, and the adjustment of such costs helps investors and others compare and analyze performance from period to period. We have also excluded the impact of pension curtailment (gains) and losses and pension settlements as such events are triggered by our restructuring and other business realignment activities and the amount of such charges vary significantly based on the size and timing of the programs.
Noncontrolling interests: This adjustment represents the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interests based on the relevant noncontrolling interest percentage.
Tax: This adjustment represents the impact of the tax effect of the pretax items excluded from Adjusted net income. The tax impact of the non-GAAP adjustments is based on the tax rates related to the jurisdiction in which the adjusted items are received or incurred.

32

Table of Contents

While acquiring brands and licenses comprises a part of our overall growth strategy, along with targeting organic growth opportunities, we have excluded acquisition-related costs and acquisition accounting impacts in connection with business combinations because these costs are unique to each transaction and the amount and frequency are not consistent and are significantly impacted by the timing and size of our acquisitions. Our management assesses the success of an acquisition as a component of performance using a variety of indicators depending on the size and nature of the acquisition, including:
the scale of the combined company by evaluating consolidated and segment financial metrics;
the expansion of product offerings by evaluating segment, brand, and geographic performance and the respective strength of the brands;
the evaluation of share expansion in categories and geographies;
the earnings per share accretion and substantial incremental free cash flow generation providing financial flexibility for us; and
the comparison of actual and projected results, including achievement of projected synergies, post integration; provided that timing for any such comparison will depend on the size and complexity of the acquisition.
Constant Currency
We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented in “constant currency”, excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using prior year foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.
Basis of Presentation of Acquisitions, Divestitures and Terminations
During the period when we complete an acquisition, divestiture or early license termination, the financial results of the current year period are not comparable to the financial results presented in the prior year period. When explaining such changes from period to period and to maintain a consistent basis between periods, we exclude the financial contribution of: (i) the acquired brands or businesses in the current year period until we have twelve months of comparable financial results and (ii) the divested brands or businesses or early terminated brands, generally, in the prior year non-comparable periods, to maintain comparable financial results with the current fiscal year period. Acquisitions, divestitures and early license terminations that would impact the comparability of financial results between periods presented in the Management’s Discussion and Analysis of Financial Condition and Results of Operations are shown in the table below.
Period of acquisition, divestiture, or termination
 
Acquisition, divestiture, or termination
 
Impact on basis of presentation
First quarter fiscal 2020
 
Divestiture: Younique - the divestiture of the interest in Foundation, which holds the net assets for Younique (Consumer Beauty segment)
 
September fiscal 2020 and 2019 financial contribution excluded. Closing date of divestiture was September 16, 2019. This effectively excludes the incremental 14 days of net revenue contribution from Younique in the prior year.
When used herein, the term “Acquisitions” and “Divestitures” or “Divestiture”, as applicable, refer to the financial contributions of the related acquisitions or divestitures and early license terminations shown above, during the period that is not comparable as a result of such acquisitions or divestitures and early license terminations.

33

Table of Contents

THREE MONTHS ENDED SEPTEMBER 30, 2019 AS COMPARED TO THREE MONTHS ENDED SEPTEMBER 30, 2018
NET REVENUES
In the three months ended September 30, 2019, net revenues decreased 4%, or $88.5, to $1,942.8 from $2,031.3 in the three months ended September 30, 2018. The impact of the lost net revenues as a result of the Divestiture, had a negative impact of 1% on the total change in net revenues in the three months ended September 30, 2019 as compared to the three months ended September 30, 2018. Excluding the impact of the lost net revenues as a result of the Divestiture, total net revenues decreased 3%, or $70.4, to $1,930.4 in the three months ended September 30, 2019 from $2,000.8 in the three months ended September 30, 2018, reflecting a decrease in unit volume of 8% and a negative foreign currency exchange translation impact of 2%, partially offset by a positive price and mix impact of 7%. The decrease in net revenues primarily reflects:
(i)
Negative share trends in the mass beauty category as a result of shelf-space losses in North America primarily for CoverGirl, Rimmel, and Clairol; and
(ii)
Declines in sales volume from strategic initiatives to reduce distribution through lower priced channels in Latin America and the Middle East primarily impacting the Consumer Beauty division.
These decreases were partially offset by the resolved supply chain disruptions that occurred in the prior year and a favorable mix impact associated with the increased proportion of net revenue contribution from higher-priced Luxury and Professional Beauty products in the three months ended September 30, 2019 as compared to the three months ended September 30, 2018.
Net Revenues by Segment
 
Three Months Ended
September 30,
 
 
(in millions)
2019
 
2018
 
Change %
NET REVENUES
 
 
 
 
 
Luxury
$
806.7

 
$
792.9

 
2
%
Consumer Beauty
716.5

 
828.8

 
(14
%)
Professional Beauty
419.6

 
409.6

 
2
%
Total
$
1,942.8

 
$
2,031.3

 
(4
%)
Luxury
In the three months ended September 30, 2019, net revenues from the Luxury segment increased 2%, or $13.8, to $806.7 from $792.9 in the three months ended September 30, 2018, reflecting a positive increase in unit volume of 6% partially offset by a negative foreign currency exchange translation impact of 2% and a negative price and mix impact of 2%. The increase in net revenues primarily reflects: (i) incremental net revenues in the travel retail distribution channel due to the resolution of the supply chain disruptions and lapping of Hurricane Florence which negatively impacted the net revenues of Hugo Boss, Gucci and Burberry in the prior year; (ii) incremental net revenues in Gucci due to the launch of Gucci Memoire as well as continued success from the relaunch of Gucci Makeup primarily benefiting the travel retail distribution channel in Asia despite the geopolitical disruptions in Hong Kong; (iii) incremental net revenues from Burberry due to continued success from the launch of Burberry Her in the second quarter of 2019 as well as continued success from the launch of Burberry Make-Up; and (iv) incremental net revenues from Chloe due to the launch of L’eau in the quarter. These increases were partially offset by (i) decreased net revenues from Calvin Klein and Tiffany & Co. due to lower launch activity in the current year compared to the prior year; (ii) decreased net revenues in philosophy due to reduced promotional activities with a key U.S. customer contributing to the negative price and mix impact for the division; and (iii) the negative impact of foreign currency exchange translation.
Consumer Beauty
In the three months ended September 30, 2019, net revenues from the Consumer Beauty segment decreased 14%, or $112.3, to $716.5 from $828.8 in the three months ended September 30, 2018. The impact of the lost net revenues from the Divestiture had a negative contribution of 2% on the total change in net revenues for the segment in the three months ended September 30, 2019 as compared to the three months ended September 30, 2018. Excluding the impact of the lost net revenues from the Divestiture, net revenues from the Consumer Beauty segment decreased 12%, or $94.2 to $704.1 in the three months ended September 30, 2019, from $798.3 in the three months ended September 30, 2018 reflecting a decrease in unit volume of 12% and a negative foreign currency exchange translation impact of 2%, partially offset by a positive price and mix impact of 2%. The decrease in net revenues primarily reflects:

34

Table of Contents

(i)
negative share trends in the mass beauty category as a result of shelf-space losses in North America primarily for CoverGirl, Rimmel, and Clairol;
(ii)
declines in sales volume from strategic initiatives to reduce distribution through lower priced channels in Latin America and the Middle East primarily impacting adidas, the retail hair line of Wella hair products, Bourjois and brands across the mass fragrance category;
(iii)
lower net revenues in the comparable periods from Younique due to a decline in presenter sponsorship; and
(iv)
the negative impact of foreign currency exchange translation.
These net revenue declines were partially offset by increased net revenues from: (i) the resolution of the supply chain disruptions which negatively impacted net revenues in the prior year; (ii) Bruno Banani primarily due to the launch of Loyal Man as well as the growth of Female Signature behind incremental working media support, and; (iii) a change in the timing of promotional activities for a key customer in Eastern Europe positively impacting priority brands across the color cosmetics category, including Max Factor.
Professional Beauty
In the three months ended September 30, 2019, net revenues from the Professional Beauty segment increased 2%, or $10.0, to $419.6 from $409.6 in the three months ended September 30, 2018, reflecting an increase in unit volume of 3% and an increase in price and mix impact of 2%, partially offset by a negative foreign currency exchange translation impact of 3%. The increase in net revenues primarily reflects: (i) incremental net revenue from the resolution of the supply chain disruptions which negatively impacted OPI and professional hair care brands across the category in the prior year, and; (ii) incremental net revenues from ghd due to continued success from the ghd Glide which launched in the third quarter of fiscal 2019.

Net Revenues by Geographic Regions
In addition to our reporting segments, net revenues by geographic regions are as follows. We define our geographic regions as North America (comprising Canada and the United States), Europe and ALMEA (comprising Asia, Latin America, the Middle East, Africa and Australia):
 
Three Months Ended
September 30,
 
 
(in millions)
2019
 
2018
 
Change %
NET REVENUES
 
 
 
 
 
North America
$
586.6

 
$
644.9

 
(9
%)
Europe
869.6

 
872.2

 
%
ALMEA
486.6

 
514.2

 
(5
%)
Total
$
1,942.8

 
$
2,031.3

 
(4
%)
North America
In the three months ended September 30, 2019, net revenues in North America decreased 9%, or $58.3, to $586.6 compared to $644.9 in the three months ended September 30, 2018. Excluding the impact of the lost net revenues as a result of the Divestiture, net revenues in North America decreased 7%, or $44.8, to $577.3 in the three months ended September 30, 2019 from $622.1 in the three months ended September 30, 2018, primarily due to: (i) negative share trends in the color cosmetics category as a result of shelf-space losses in the United States primarily for CoverGirl and Rimmel; (ii) decreased net revenues from Younique in the comparable periods due to a decline in presenter sponsorship; and (iii) decreased net revenues from Calvin Klein due to lower launch activity in the current year compared to the prior year. These decreases were partially offset by increased net revenues from: (i) Gucci due to the launch of Gucci Memoire as well as continued success from the prior year launch of Gucci Guilty Pour Femme; and (ii) the resolution of the supply chain disruptions which negatively impacted the net revenues from OPI and professional hair care brands across the category in the prior year.
Europe
In the three months ended September 30, 2019, net revenues in Europe remained consistent at $869.6 compared to $872.2 in the three months ended September 30, 2018. The impact of the lost net revenues as a result of the Divestiture was inconsequential to the region’s net revenue performance. The underlying net revenue performance includes: (i) decreased net revenues in the United Kingdom due to negative category trends for color cosmetics; and (ii) decreased net revenues across the region from the professional hair care due to lower launch activity in the current year. These decreases were offset by: (i) increased net revenues from the Travel Retail business impacting Gucci, Hugo Boss and Burberry primarily due to the supply

35

Table of Contents

chain disruptions in the prior year; (ii) increased net revenues from Bruno Banani in Germany primarily due to the launch of Loyal Man as well as the growth of Female Signature behind incremental working media support; (iii) increased net revenues due to a change in the timing of promotional activities for a key customer in Eastern Europe positively impacting priority brands across the color cosmetics category, including Max Factor; and (iv) increased net revenues from ghd due to the continued success from the ghd Glide which launched in the third quarter of fiscal 2019. Excluding the impact of the negative foreign currency exchange translation impact of 4%, net revenues in Europe increased 4%.
ALMEA
In the three months ended September 30, 2019, net revenues in ALMEA decreased 5%, or $27.6, to $486.6 from $514.2 in the three months ended September 30, 2018. The impact of the lost net revenues as a result of the Divestiture was inconsequential to the region’s net revenue performance. The net revenue decrease primarily reflects declining sales volume from strategic initiatives to reduce distribution through lower priced channels in Latin America and the Middle East primarily impacting adidas, the retail hair line of Wella hair products, Bourjois and brands across the mass fragrance category. These decreases were partially offset by incremental net revenues in Gucci due to the launch of Gucci Memoire as well as continued success from the relaunch of Gucci Makeup primarily benefiting the travel retail distribution channel in Asia despite the geopolitical disruptions in Hong Kong. Excluding the impacts of the negative foreign currency exchange translation impact of 2%, net revenues in ALMEA decreased 3%.
COST OF SALES
In the three months ended September 30, 2019, cost of sales decreased 9%, or $70.7, to $738.4 from $809.1 in the three months ended September 30, 2018. Cost of sales as a percentage of revenues decreased to 38.0% in the three months ended September 30, 2019 from 39.8% in the three months ended September 30, 2018, resulting in a gross margin improvement of approximately 180 basis points, primarily reflecting:
(i)
a favorable mix impact associated with the increased proportion of net revenue contribution from higher-margin Luxury and Professional Beauty products in the three months ended September 30, 2019 as compared to the three months ended September 30, 2018;
(ii)
declines in sales volume from strategic initiatives to reduce distribution through lower priced channels in Latin America and the Middle East primarily impacting adidas, the retail hair line of Wella hair products, Bourjois and brands across the mass fragrance category;
(iii)
decreased manufacturing costs within the Luxury segment reflecting optimization of our manufacturing footprint and the resolution of the prior year supply chain disruptions, and;
(iv)
decreased excess and obsolescence expense on inventory in the Corporate segment for artwork transition activities on acquired inventory in connection with the acquisition of the P&G Beauty Business.
These improvements were partially offset by increased excess and obsolescence expense on inventory in the Consumer Beauty segment.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
In the three months ended September 30, 2019, selling, general and administrative expenses decreased 4%, or $49.7, to $1,072.6 from $1,122.3 in the three months ended September 30, 2018. Selling, general and administrative expenses as a percentage of net revenues decreased to 55.2% in the three months ended September 30, 2019 from 55.3% in the three months ended September 30, 2018, or approximately 10 basis points. This decrease primarily reflects:
(i)
40 basis points related to lower administrative costs due to compensation expense savings as a result of previous restructuring programs; and
(ii)
40 basis points related to positive transactional impact from our exposure to foreign currency exchange fluctuations.
These decreases were partially offset by an increase of 70 basis points in advertising and consumer promotion costs primarily reflecting an increase in working media investments behind the color cosmetics category, out-pacing the decrease in non-strategic advertising and consumer promotion investments in the fragrance and professional hair care categories.


36

Table of Contents


OPERATING INCOME (LOSS)
In the three months ended September 30, 2019, operating income (loss) increased greater than 100%, or $146.7, to income of $126.0 from a loss of $20.7 in the three months ended September 30, 2018. Operating margin, or operating income as a percentage of net revenues, increased to 6.5% in the three months ended September 30, 2019 as compared to (1.0%) in the three months ended September 30, 2018.
The basis point increase in operating income as a percentage of net revenues for the three months ended September 30, 2019 as compared to the respective prior year period, are comprised of the following:
 
Three Months Ended
September 30,
(bps rounded to nearest tenth)
2019/2018
Gain on sale of business
430

Cost of sales
180

Asset impairment charges
60

Restructuring
50

Amortization
20

Selling, general and administrative expenses
10

Total basis point increase
750

Operating Income by Segment
 
Three Months Ended
September 30,
 
 
(in millions)
2019
 
2018
 
Change %
Operating income (loss)
 
 
 
 
 
Luxury
$
90.3

 
$
48.7

 
85
%
Consumer Beauty
(43.3
)
 
(18.6
)
 
<(100%)

Professional Beauty
24.4

 
5.0

 
>100%

Corporate
54.6

 
(55.8
)
 
>100%

Total
126.0

 
(20.7
)
 
>100%

Luxury
In the three months ended September 30, 2019, operating income for Luxury increased 85%, or $41.6, to $90.3 from $48.7 in the three months ended September 30, 2018. Operating margin increased to 11.2% of net revenues in the three months ended September 30, 2019 as compared to 6.1% in the three months ended September 30, 2018, primarily driven by lower cost of goods sold as a percentage of net revenues, lower selling, general, and administrative costs as a percentage of net revenues, and lower amortization as a percentage of net revenues.
Consumer Beauty
In the three months ended September 30, 2019, operating loss for Consumer Beauty increased greater than 100%, or $24.7, to a loss of $43.3 from a loss of $18.6 in the three months ended September 30, 2018. Operating margin decreased to (6.0)% of net revenues in the three months ended September 30, 2019 as compared to (2.2)% in the three months ended September 30, 2018, primarily driven by higher working media investments in color cosmetics.
Professional Beauty
In the three months ended September 30, 2019, operating income for Professional Beauty increased greater than 100%, or $19.4, to $24.4 as compared to $5.0 in the three months ended September 30, 2018. Operating margin increased to 5.8% of net revenues in the three months ended September 30, 2019 as compared to 1.2% in the three months ended September 30, 2018, primarily driven by lower selling, general, and administrative costs as a percentage of net revenues, lower cost of goods sold as a percentage of net revenues, and lower amortization as a percentage of net revenues.

37

Table of Contents

Corporate
Corporate primarily includes income and expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.
In the three months ended September 30, 2019, the operating income for Corporate was $54.6 compared to an expense of $(55.8) in the three months ended September 30, 2018, as described under “Adjusted Operating Income for Coty Inc.” below. The increase to operating income for Corporate was primarily driven by the divestiture of Younique resulting in $84.5 of income reflected in Gain on sale of business in the Condensed Consolidated Statements of Operations for the three months ended September 30, 2019.
Adjusted Operating Income by Segment
We believe that adjusted operating income by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income (loss) to adjusted operating income is presented below, by segment:
 
Three Months Ended September 30, 2019
(in millions)
Reported
(GAAP)
 
Adjustments (a)
 
Adjusted
(Non-GAAP)
Operating income (loss)
 
 
 
 
 
Luxury
$
90.3

 
$
(38.0
)
 
$
128.3

Consumer Beauty
(43.3
)
 
(29.1
)
 
(14.2
)
Professional Beauty
24.4

 
(17.2
)
 
41.6

Corporate
54.6

 
55.6

 
(1.0
)
Total
126.0

 
(28.7
)
 
154.7

 
Three Months Ended September 30, 2018
(in millions)
Reported
(GAAP)
 
Adjustments (a)
 
Adjusted
(Non-GAAP)
Operating (loss) income
 
 
 
 
 
Luxury
$
48.7

 
$
(52.9
)
 
$
101.6

Consumer Beauty
(18.6
)
 
(33.4
)
 
14.8

Professional Beauty
5.0

 
(18.8
)
 
23.8

Corporate
(55.8
)
 
(56.4
)
 
0.6

Total
(20.7
)
 
(161.5
)
 
140.8

 
 
(a) 
See a reconciliation of reported operating income to adjusted operating income and a description of the adjustments under “Adjusted Operating Income for Coty Inc.” below. All adjustments are reflected in Corporate, except for amortization expense, which is reflected in the Luxury, Consumer Beauty and Professional Beauty divisions.
Adjusted Operating Income for Coty Inc.
We believe that adjusted operating income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating income to adjusted operating income is presented below:

38

Table of Contents

 
Three Months Ended
September 30,
 
 
(in millions)
2019
 
2018
 
Change %
Reported operating income (loss)
$
126.0

 
$
(20.7
)
 
>100%

% of net revenues
6.5
%
 
(1.0
%)
 
 
Amortization expense
84.3

 
92.5

 
(9
%)
Restructuring and other business realignment costs
28.9

 
56.4

 
(49
%)
Gain on sale of business
(84.5
)
 

 
N/A

Asset impairment charges

 
12.6

 
(100
%)
Total adjustments to reported operating income
28.7

 
161.5

 
(82
%)
Adjusted operating income (loss)
$
154.7

 
$
140.8

 
10
%
% of net revenues
8.0
%
 
6.9
 %
 
 
In the three months ended September 30, 2019, adjusted operating income increased 10%, or $13.9 to $154.7 from $140.8 in the three months ended September 30, 2018. Adjusted operating margin increased to 8.0% of net revenues in the three months ended September 30, 2019 from 6.9% in the three months ended September 30, 2018, primarily driven by approximately 160 basis points related to lower cost of sales as a percentage of net revenues partially offset by 50 basis points related to higher selling, general and administrative costs as a percentage of net revenues reflecting the higher working media investments in the color cosmetics category. Excluding the impact of foreign currency exchange translations, adjusted operating income increased 14%.
Gain on sale of business
On September 16, 2019, the Company completed the divestiture of Younique resulting in a gain of $84.5 included in Gain on sale of business in the Condensed Consolidated Statements of Operations for the three months ended September 30, 2019.
Amortization Expense
In the three months ended September 30, 2019, amortization expense decreased to $84.3 from $92.5 in the three months ended September 30, 2018. In the three months ended September 30, 2019, amortization expense of $38.0, $29.1, and $17.2 was reported in the Luxury, Consumer Beauty and Professional Beauty segments, respectively. In three months ended September 30, 2018, amortization expense of $40.3, $33.4, and $18.8 was reported in the Luxury, Consumer Beauty, and Professional Beauty segments, respectively.
Restructuring and Other Business Realignment Costs
We continue to analyze our cost structure, including opportunities to simplify and optimize operations. On July 1, 2019, we announced our Turnaround Plan. To implement the Turnaround Plan, we expect to incur restructuring and other business realignment costs, in addition to costs associated with previously announced programs. The Company expects incremental cash costs related to the Turnaround Plan to be approximately $600.0. In addition, the Company will continue to incur cash costs of $160.0 related to restructuring and other business realignment costs connected to previously announced programs.
Prior to July 1, 2019, we incurred restructuring and related costs aimed at integrating and optimizing the combined organization following the acquisition of the P&G Beauty Business, which we refer to as the Global Integration Activities, and reducing fixed costs and enabling further investment in the business, which we refer to as the 2018 Restructuring Actions.
In the three months ended September 30, 2019, we incurred restructuring and other business structure realignment costs of $28.9, as follows:
We incurred restructuring costs of $6.0 primarily related to the Turnaround Plan, included in the Condensed Consolidated Statements of Operations; and
We incurred business structure realignment costs of $22.9 primarily related to the Turnaround Plan, included in Selling, general and administrative expenses in the Condensed Consolidated Statement of Operations.
In the three months ended September 30, 2018, we incurred restructuring and other business structure realignment costs of $56.4 as follows:
We incurred restructuring costs of $15.5 primarily related to the Global Integration Activities and 2018 Restructuring Actions, included in the Condensed Consolidated Statements of Operations; and

39

Table of Contents

We incurred business structure realignment costs of $40.9 primarily related to our Global Integration Activities and certain other programs. This amount includes $35.7 reported in selling, general and administrative expenses and $5.2 reported in cost of sales in the Condensed Consolidated Statements of Operations.
In all reported periods, all restructuring and other business realignment costs were reported in Corporate.
Asset Impairment Charges
In the three months ended September 30, 2019 we did not incur any asset impairment charges.    
In the three months ended September 30, 2018, we acquired a trademark associated with a pre-existing license. As a result of the acquisition, the preexisting license was effectively terminated, and accordingly the Company recorded $12.6 of asset impairment charges in the Condensed Consolidated Statement of Operations related to the license agreement.
INTEREST EXPENSE, NET
In the three months ended September 30, 2019, Interest expense, net was $77.4 as compared with $64.1 in the three months ended September 30, 2018. This increase is primarily driven by higher interest rates and the impact of transactional foreign exchange.
INCOME TAXES
The effective income tax rate for the three months ended September 30, 2019 and 2018 was (21.3%) and 88.5%, respectively. The negative effective tax rate in the three months ended September 30, 2019 results from reporting income before taxes and a benefit for income taxes. The positive effective tax rate in the three months ended September 30, 2018 results from reporting losses before income taxes and a benefit for income taxes. The change in the effective tax rate for the three months ended September 30, 2019, as compared to the three months ended September 30, 2018, is primarily due to the U.S. GAAP treatment of the Younique disposition in the current period and a $30.0 favorable Swiss tax ruling in the prior period.
The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to our unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.
Reconciliation of Reported (Loss) Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:
 
Three Months Ended
September 30, 2019
 
Three Months Ended
September 30, 2018
(in millions)
Income Before Income Taxes
 
(Benefit) Provision for Income Taxes
 
Effective Tax Rate
 
(Loss) Income Before Income Taxes
 
(Benefit) Provision for Income Taxes
 
Effective Tax Rate
Reported income (loss) before income taxes
$
46.4

 
$
(9.9
)
 
(21.3
%)
 
$
(87.5
)
 
$
(77.4
)
 
88.5
%
Gain on sale of business adjustment (a) (b)
(84.5
)
 
4.8

 
 
 
 
 
 
 
 
Other adjustments to reported operating income (a) (b)
113.2

 
22.7

 
 
 
161.5

 
65.1

 
 
Adjusted income before income taxes
$
75.1

 
$
17.6

 
23.4
%
 
$
74.0

 
$
(12.3
)
 
(16.6
%)
 
 
(a) 
See a description of adjustments under “adjusted operating income for Coty Inc.”
(b) 
The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.
The adjusted effective tax rate was 23.4% for the three months ended September 30, 2019 compared to (16.6%) for the three months ended September 30, 2018. The differences were primarily due to a $30.0 tax benefit recognized as a result of a favorable Swiss tax ruling in the prior period.



40

Table of Contents

NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC.
Net income (loss) attributable to Coty Inc. increased to income of $52.3 in the three months ended September 30, 2019 from a loss of $12.1 in the three months ended September 30, 2018. This increase primarily reflects the Divestiture resulting in income included in Gain on sale of business in the Condensed Consolidated Statements of Operations for the three months ended September 30, 2019, net of the related tax effect.
We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”
 
Three Months Ended
September 30,
 

(in millions)
2019
 
2018
 
Change %
Reported net income (loss) attributable to Coty Inc.
$
52.3

 
$
(12.1
)
 
>100%

% of net revenues
2.7
%
 
(0.6
%)
 
 
Adjustments to reported operating income (a)
28.7

 
161.5

 
(82
%)
Adjustments to noncontrolling interests (b)
(3.0
)
 
(3.8
)
 
21
%
Change in tax provision due to adjustments to reported net income attributable to Coty Inc.
(27.5
)
 
(65.1
)
 
58
%
Adjusted net income attributable to Coty Inc.
$
50.5

 
$
80.5

 
(37
%)
% of net revenues
2.6
%
 
4.0
 %
 
 

Per Share Data
 
 
 
 
 
Adjusted weighted-average common shares
 
 
 
 
 
Basic
754.2

 
750.8

 
 
Diluted
758.9

 
752.7

 
 
Adjusted net income attributable to Coty Inc. per common share
 
 
 
 
 
Basic
$
0.07

 
$
0.11

 
 
Diluted
0.07

 
0.11

 
 
 
 
(a) 
See a description of adjustments under “Adjusted Operating Income for Coty Inc.”
(b) 
The amounts represent the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interest based on the relevant noncontrolling interest percentage in the Consolidated Statements of Operations.
FINANCIAL CONDITION
LIQUIDITY AND CAPITAL RESOURCES
Overview
Our primary sources of funds include cash expected to be generated from operations, borrowings from issuance of debt and committed and uncommitted lines of credit provided by banks and lenders in the U.S. and abroad. As of September 30, 2019, we had cash and cash equivalents of $350.4 compared with $340.4 as of June 30, 2019.
Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during the three and six months buildup before the holiday season in anticipation of higher global sales during the second fiscal quarter, as well as cash demands immediately following the holiday season primarily related to post-holiday sales returns. In the second fiscal quarter, we typically experience strong cash generation as a result of increased demand by retailers associated with the holiday season. Our principal uses of cash are to fund operating expenditures, capital expenditures, business structure realignment expenditures, interest payments, acquisitions, dividends, share repurchases and any principal payments on debt. Working capital movements are influenced by the sourcing of materials related to the production of products within each of our segments. Cash and working capital management initiatives, including the phasing of vendor payments and factoring of trade receivables from time-to-time, may also impact the timing of our operating cash flows, as we seek to efficiently manage our cash and working capital requirements.
As a result of the cash on hand, our expected ability to generate cash from operations and through access to our revolving credit facility and other lending sources, we believe we have sufficient liquidity to meet our ongoing needs on both a near term and long-term basis. On an ongoing basis, we factor trade receivables under our receivables purchase facilities. We may also, from time to time phase vendor payments in order to supplement the timing of our cash flows.

41

Table of Contents

Debt
See Note 9Debt in the notes to our Consolidated Financial Statements for additional information on our debt arrangements and prior period credit agreements.
Based on our credit agreement (the “2018 Coty Credit Agreement”), as amended, the calculation of our financial covenant for net debt excludes the impact of operating leases, and thus, the adoption of the new leasing standard, ASU 2016-02, Leases (Topic 842), (See Note 2Summary of Significant Accounting Policies), did not impact our financial covenants. In order to be consistent with our financial covenant, we will continue to report our net debt calculation excluding operating leases.
Factoring of Receivables
From time to time, we supplement the timing of our cash flows through the factoring of trade receivables. In this regard, we have entered into factoring arrangements with a financial institution. Most recently, these agreements included the following:
U.S. Receivables Purchase Agreement
In March of fiscal 2019, we entered into a receivables purchase agreement with a financial institution, with an aggregate facility limit of $150.0 to facilitate factoring of receivables by certain of our U.S. subsidiaries (the “U.S. Receivables Purchase Agreement”). Factoring of such receivables under the U.S. Receivables Purchase Agreement may be executed on a recourse or non-recourse basis.
During the three months ended September 30, 2019, total cash received for trade receivables factored under the U.S. Receivables Purchase Agreement, net of collections and factoring costs, was $123.7. Gross trade receivables factored under the U.S. Receivables Purchase Agreement during the three months ended September 30, 2019 totaled $142.2.
European Receivables Purchase Agreement
In September of fiscal 2020, we entered into a factoring agreement with a financial institution, which allows for the transfer of receivables from certain of our European subsidiaries, in exchange for cash (the “European Receivables Purchase Agreement”). The total outstanding amount permitted among such subsidiaries is €93.0 million. Factoring of such receivables under the European Receivables Purchase Agreement is executed on a non-recourse basis.
During the three months ended September 30, 2019, total cash received for trade receivables factored under the European Receivables Purchase Agreement, net of collections and factoring costs, was $70.1. Gross trade receivables factored under the European Receivables Purchase Agreement during the three months ended September 30, 2019 totaled $81.6. Remaining balances due from the factor amounted to $8.5, as of September 30, 2019.
Cash Flows
 
Three Months Ended
September 30,


2019
 
2018
Condensed Consolidated Statements of Cash Flows Data:
(in millions)
 
 
 
Net cash provided by (used in) operating activities
$
39.9

 
$
(81.9
)
Net cash used in investing activities
(60.8
)
 
(174.4
)
Net cash provided by financing activities
36.7

 
351.8

Net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities was $39.9 and $(81.9) for the three months ended September 30, 2019 and 2018, respectively. The increase in operating cash inflows in the first quarter of the current year compared to prior year was $121.8. Operating cash flows were positively impacted by changes in working capital accounts which contributed to $105.7 of the total increase. Changes in accrued expenses and current liabilities were the primary driver of the increase in cash flows as a result of lower payments for restructuring and business realignment programs.  Furthermore, cash flows from trade receivables were positively impacted in the current year due to the implementation of the factoring facilities in the U.S. and Europe during the past six months.  Fluctuations in other working capital accounts were in line with prior year.
Net cash used in investing activities

42

Table of Contents

Net cash used in investing activities was $60.8 and $174.4 for the three months ended September 30, 2019 and 2018, respectively. The decrease in net cash used in investing activities of $113.6 related to lower capital expenditures of $47.2, $40.8 of payments for business combinations and asset acquisitions made in prior year which did not reoccur, and $25.6 of net cash proceeds from the sale of the Younique business, which took place during the first three months of fiscal 2020.
Net cash provided by financing activities
During the three months ended September 30, 2019, net cash provided by financing activities was $36.7 and $351.8 for the three months ended September 30, 2019 and 2018, respectively. The decrease in cash provided by financing activities of $315.1 was primarily driven by lower net cash inflows associated with the Company’s revolving loan facilities of $336.0. Additionally, during the three months ended September 30, 2019, a $45.0 payment was made to purchase the remaining mandatorily redeemable noncontrolling interest in the Company’s Southeast Asian subsidiary, which did not occur in the prior year. The impact of this cash outflow was partially offset by lower cash used for dividend payments as a result of the Company’s Stock Dividend Reinvestment Program, which became available to stockholders in the fourth quarter of fiscal 2019.
Dividends
On May 8, 2019, the Board approved a stock dividend reinvestment program giving shareholders the option to receive their full dividend in cash or to receive their dividend in 50% cash / 50% common stock. Shareholders will be able to make this election on a quarterly basis. The percentage of our total Common Stock for which the shareholders elected to participate in the Stock Dividend Reinvestment Program for the September 30, 2019 dividend was 69%.
As may be declared by the Board of Directors (the “Board”), we anticipate issuing future dividends on a quarterly basis.
For additional information on our Share Repurchase Program, see Note 13Equity in the notes to our Consolidated Financial Statements.
Treasury Stock - Share Repurchase Program
For additional information on our Share Repurchase Program, see Note 13Equity in the notes to our Consolidated Financial Statements.
Commitments and Contingencies
Mandatorily Redeemable Financial Interest
United Arab Emirates subsidiary
We are required under a shareholders agreement (the “U.A.E. Shareholders Agreement”) to purchase all of the shares held by the noncontrolling interest holder equal to 25% of a certain subsidiary in the United Arab Emirates (the “U.A.E. subsidiary”) at the termination of the agreement. We have determined such shares to be an MRFI that is recorded as a liability. The liability is calculated based upon a pre-determined formula in accordance with the U.A.E Shareholders Agreement. As of September 30, 2019 and June 30, 2019, the liability amounted to $7.1 and $7.5, of which $5.1 and $6.1, respectively, was recorded in Other noncurrent liabilities and $2.0 and $1.4, respectively, was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.
Southeast Asian subsidiary
In July 2019, we purchased the remaining 49% noncontrolling interest of a certain Southeast Asian subsidiary from the noncontrolling interest holder for $45.0, pursuant to a Sale of Shares and Termination Deed, as amended. The termination was effective on June 30, 2019 and immediately prior to the cash purchase of the remaining noncontrolling interest, the noncontrolling interest balance was recorded as a MRFI liability. As of September 30, 2019, the remaining MRFI liability of $7.2, which was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet, relates to remaining retained earnings and will be paid out as dividends by December 31, 2019.
Redeemable Noncontrolling Interests
Noncontrolling interests, where we may be required to repurchase the noncontrolling interest under a put option or other contractual redemption requirement, are reported in the Condensed Consolidated Balance Sheet between liabilities and equity, as redeemable noncontrolling interests (“RNCI”). We adjust the RNCI to the higher of the redemption value or the carrying value (the acquisition date fair value adjusted for the noncontrolling interest’s share of net income (loss) and dividends) on each balance sheet date with changes recognized as an adjustment to additional paid-in capital (“APIC”).

43

Table of Contents

Younique
On September 16, 2019, we completed the sale of all our membership interest in Foundation which held the net assets of Younique. On the date of this transaction, the Younique membership holders had a 40.7% membership interest in Foundation. See Note 5Business Combinations and Divestitures. As a result of the sale of our membership interest in Foundation, RNCI of $360.4 was derecognized as of the date of sale.
We accounted for the 40.7% noncontrolling interest portion of Foundation as redeemable noncontrolling interest (“RNCI”) due to the noncontrolling interest holder’s right to put their shares to us in certain circumstances. Foundation was a majority-owned consolidated subsidiary through September 16, 2019 and we recorded income tax expense based on our 59.3% membership interest in Foundation due to its treatment as a partnership for U.S. income tax purposes. Accordingly, Foundation’s net income attributable to RNCI is equal to the 40.7% noncontrolling interest of Foundation’s net income excluding a provision for income taxes. We recognized $365.3 as the RNCI balance as of June 30, 2019.
Subsidiary in the Middle East
As of September 30, 2019, the noncontrolling interest holder in our subsidiary in the Middle East (“Middle East Subsidiary”) had a 25% ownership share. We recognized $94.6 and $86.5 as the RNCI balances as of September 30, 2019 and June 30, 2019, respectively.
Legal Contingencies
Brazilian Tax Assessments
In connection with a local tax audit of one of our subsidiaries in Brazil, we were notified of tax assessments issued in March of 2018. The assessments relate to local sales tax credits, which the Treasury Office of the State of Goiás considers improperly registered for the 2016-2017 tax periods. We are currently seeking a favorable administrative decision on the tax enforcement action filed by the Treasury Office of the State of Goiás. These tax assessments, including estimated interest and penalties, through September 30, 2019 amount to a total of R$249.0 million (approximately $59.8). We believe we have meritorious defenses and we have not recognized a loss for these assessments as we do not believe a loss is probable.
Off-Balance Sheet Arrangements
We had undrawn letters of credit of $5.0 and $6.3 and bank guarantees of $51.8 and $97.1 as of September 30, 2019 and June 30, 2019, respectively.
Contractual Obligations
Our principal contractual obligations and commitments as of September 30, 2019 are summarized in Item 7 - "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Contractual Obligations and Commitments," of our Fiscal 2019 Form 10-K, except as noted above. For the three months ended September 30, 2019, there have been no material changes in our contractual obligations outside the ordinary course of business.
Critical Accounting Policies
We believe that the critical accounting policies listed below involve our more significant judgments, assumptions and estimates and, therefore, could have the greatest potential impact on our Condensed Consolidated Financial Statements:
Revenue Recognition;
Goodwill, Other Intangible Assets and Long-Lived Assets;
Business Combinations;
Inventory; and
Income Taxes.
As part of our quarterly review of the critical accounting policies, we concluded that the assumptions around Pension Benefit Costs and Redeemable Noncontrolling Interests no longer involved significant judgments, assumptions or estimates due to changes in our business, and thus excluded these policies from the above list. As of September 30, 2019, there have been no other material changes to the items disclosed as critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II—Item 7 of our Fiscal 2019 Form 10-K.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in market risk from the information provided in Item 7A. Quantitative and Qualitative Disclosures About Market Risk of our Fiscal 2019 Form 10-K.

44

Table of Contents

Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Our management, with the participation of our Chief Executive Officer (the “CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2019. Based on the evaluation of our disclosure controls and procedures as of September 30, 2019, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(f) of the Exchange Act during the first fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Part II. OTHER INFORMATION
Item 1. Legal Proceedings.
We are involved, from time to time, in various litigation and administrative and other legal proceedings, including regulatory actions, incidental or related to our business, including consumer class or collective actions, personal injury (including asbestos-related claims), intellectual property, competition, non-compete, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While we cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon our business, prospects, financial condition, results of operations, cash flows, as well as the trading price of our securities. However, management’s assessment of our Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings pending against us not presently known to us or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, we are in discussions with regulators, including discussions initiated by us, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks. As the outcomes of such proceedings are unpredictable, we can give no assurance that the results of any such proceedings will not materially affect our reputation, our business, prospects, financial condition, results of operations, cash flows or the trading price of our securities.
Certain Litigation. Two purported stockholder class action complaints concerning the tender offer by Cottage Holdco B.V. (the “Cottage Tender Offer”) and the Schedule 14D-9 were filed by putative stockholders against the Company and the directors of the Company in the U.S. District Court for the District of Delaware, but have not yet been served. In both complaints, the plaintiffs allege that the Company’s Schedule 14D-9 omits certain information, including, among other things,

45

Table of Contents

certain financial data and certain analyses underlying the opinion of Centerview Partners LLC. Plaintiffs assert claims under the federal securities laws and seek, among other things, injunctive and/or monetary relief. The cases are captioned Phillips v. Coty, Inc., et al., Case No. 1:19-cv-00628-LPS and Rumsey v. Coty, Inc., et al., Case No. 1:19-cv-00650-LPS. On October 31, 2019, the plaintiffs in Phillips v. Coty voluntarily dismissed their complaint with prejudice.
A third consolidated purported stockholder class action and derivative complaint concerning the Cottage Tender Offer and the Schedule 14D-9 is pending against the directors of the Company, JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. in the Court of Chancery of the State of Delaware. The Company was named as a nominal defendant. The case, which was filed on May 6, 2019, was captioned Massachusetts Laborers’ Pension Fund v. Harf et.al., Case No. 2019-0336-CB. On June 14, 2019, plaintiffs in the consolidated action filed a Verified Amended Class Action and Derivative Complaint (“Amended Complaint”). After defendants responded to the Amended Complaint, on October 21, 2019, plaintiffs filed a Verified Second Amended Class Action and Derivative Complaint (the “Second Amended Complaint”), alleging that the directors and JAB Holding Company, S.à.r.l., JAB Cosmetics B.V., and Cottage Holdco B.V. breached their fiduciary duties to the Company’s stockholders and breached the Stockholders Agreement. The Second Amended Complaint seeks, among other things, monetary relief. The defendants’ responses to the Second Amended Complaint are due on November 21, 2019.
Item 1A. Risk Factors.
We have disclosed information about the risk factors that could adversely affect our business in Part I, Item 1A under the heading “Risk Factors” in our Annual Report on Form 10-K for fiscal 2019. There have been no material changes to these risk factors.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
No shares of our Class A Common Stock were repurchased during the fiscal quarter ended September 30, 2019.

46

Table of Contents

Item 6. Exhibits, Financial Statement Schedules.
The exhibits listed below are filed as part of this Quarterly Report on Form 10-Q:
Exhibit Number
 
Description
 
 
 
 
 
 
 
101.INS
 
Inline XBRL Instance Document.
101.SCH
 
Inline XBRL Taxonomy Extension Schema Document.
101.CAL
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF
 
Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB
 
Inline XBRL Taxonomy Extension Labels Linkbase Document.
101.PRE
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104
 
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
Exhibit is a management contract or compensatory plan or arrangement.

47

Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
COTY INC.
 
 
 
 
Date: November 6, 2019
 
By:
/s/Pierre Laubies
 
 
 
Name: Pierre Laubies
 
 
 
Title: Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/Pierre-André Terisse
 
 
 
Name: Pierre-André Terisse
 
 
 
Title: Chief Financial Officer
 
 
 
(Principal Financial Officer)


48



Separation and Termination Agreement
by and between
HFC Prestige International Operations Switzerland Sàrl    (hereinafter the Company)
Chemin Louis-Hubert 1-3, 1213 Petit-Lancy (GE), Switzerland

and

Mr. Luc Volatier                        (hereinafter the Executive)
Bloemgracht 164
1015TT
Amsterdam
The Netherlands



(together the Parties)






Whereas
A.
The Company and the Executive have entered into an employment agreement with effect as of January 14, 2019 (the Employment Agreement), and a Confidentiality, Non-Competition and Non-Solicitation Agreement with effect as of January 14, 2019 (the Restrictive Covenant Agreement), a copy of which is attached as Annex 1 hereto.
B.
On September 9, 2019, the Executive gave notice of termination to the Company under Section 4 of the Employment Agreement and Section 11 of the Restrictive Covenant Agreement.
C.
The Company and the Executive wish to settle amicably all aspects of the employment relationship and the termination thereof, subject to the terms and conditions set forth herein.
Now, therefore, the Parties hereto enter into the following agreement (the Agreement):
1.
Termination
The Executive's employment with the Company shall terminate with effect as of March 31, 2020 (the Termination Date). For the avoidance of any doubt, the Termination Date shall not be subject to any deferment for whatever reason.
Until the Termination Date, subject to Articles 2 and 3, the Company shall pay the Executive the salary of CHF 45'999.7 per month (gross) plus reimbursement of expenses of monthly CHF 8'167.-, plus the Executive’s car allowance of CHF 1’900.- per month (gross), plus the Executive’s health insurance participation payment of CHF 500.- per month (gross) .
2.
Release from Obligation to Work
The Executive is hereby released irrevocably from his obligation to work (i.e., placed on garden leave) with immediate effect as of the date of this Agreement (the Release Date). In addition, the Executive shall execute the resignation letter attached hereto as Annex 2, pursuant to which he shall resign as a member of the board of directors of the Company effective as of the Release Date, and the resignation letter attached hereto as Annex 3, pursuant to which he shall resign as an executive officer of Coty, Inc. and its affiliates and from all offices, committee positions and board positions, if any, then held with Coty, Inc. or any of its affiliates, effective as of the Release Date, and the Executive agrees to execute any and all additional reasonable documents necessary to effectuate such resignations.
Notwithstanding the foregoing, the Executive shall remain available to the Company to provide services as may be requested by the Company until the Termination Date to allow for a smooth transition of his duties.
Subject to Article 3, the payments described in Article 1 shall be paid regularly until the Termination Date, provided, however, that the Company may, in its sole discretion, terminate the Executive’s employment with the Company prior to the Termination Date with immediate effect, by electing to pay at that time a lump sum in lieu of notice equal to the payments to which the Executive would have been entitled to receive during the remainder of the notice period as per Article 1 above.





3.
Commencement of New Work
Until the Termination Date, the Executive may only accept a new employment or perform any other professional activity after having obtained the prior written consent of the Company, and in all cases, subject to the Executive’s continued compliance with Articles 2, 3 and 8 of this Agreement.
If (i) the Executive starts a new employment (in compliance with this Article 3) or (ii) if the Company elects to pay the all or the remaining payments described in Article 1 in a lump sum in lieu of notice (in compliance with Article 2), then, in either case, (a) the Termination Date shall automatically be moved to the last business day prior to such date of new employment or payment in lump sum, as applicable (the New Termination Date), (b) the employment with the Company is terminated with effect as per the New Termination Date, and (c) the term "Termination Date" as used in this Agreement means "New Termination Date".
In addition, if the Executive starts a new employment (in compliance with this Article 3), the Company's obligation to make the payments described in Article 1 of this Agreement shall cease as of the New Termination Date, and the Company shall be entitled to reclaim any overpayment made to the Executive under Article 1 of this Agreement. The Executive is obliged to inform the Company in writing and without delay about the start of any such new employment.
For the avoidance of doubt, if the Executive starts a new employment before the Termination Date, in each case, in compliance with this Article 3, the Executive shall continue to be eligible to receive the payments and benefits described in Articles 4, 5, 7, 11, and 12 in accordance with their terms.
4.
Entitlement to Vacation and Overtime
At the same time that the Company pays the Lump Sum, the Company shall pay the Executive an additional amount in respect of the Executive’s accrued but unpaid time off ("heures supplémentaires" and "travail supplémentaire") as of the Release Date. The Executive shall have no further rights to accrue or use any such time off other than as set forth in the preceding sentence.
5.
Lump Sum Payment
In consideration of the Executive executing and performing this Agreement (including, without limitation, the Executive’s continued compliance with Articles 2, 3, and 8 of this Agreement) and in full discharge of any claims and rights of the Executive arising out of or in connection with the Employment Agreement and its termination, whether actual or potential, whether present or future, the Company will pay to the Executive, in addition to the payments described in Article 1, the lump sum of U.S. $800,000 gross (the Lump Sum). The payment of the Lump Sum is made without acknowledgement of any legal obligation of the Company.
6.
Payment Terms
The payment of the Lump Sum shall be made to the bank account of the Executive to which the regular salary payments have been made within 10 days after delivery to the Company of a waiver and release in the form attached hereto as Annex 4 validly executed by the Executive. The Executive shall execute





and deliver such waiver and release not earlier than one (1) month and one (1) day and not later than three (3) months after the Termination Date.
For the avoidance of doubt, in the event the Executive breaches Articles 2, 3 or 8 of this Agreement, the Company’s obligation under this Article 6 shall cease as of the date of such breach, and the Company shall be entitled to reclaim any amounts paid to the Executive under this Article 6.
From all payments under this Agreement all applicable deductions will be made, i.e., deductions for social security (including pension funds) and tax, if any, as per the applicable laws and the applicable regulations of the Company.
7.
Annual Performance Plan and Equity & Long Term Incentive Plan
For the avoidance of doubt, for purposes of each of (i) the Amended and Restated Coty Inc. Annual Performance Plan (as of February 1, 2017) (the APP) and any awards granted to the Executive thereunder, (ii) the Amended and Restated Coty Inc. Equity and Long-Term Incentive Plan (as amended and restated on February 1, 2017) (the ELTIP) and the restricted share units granted thereunder to the Executive pursuant to the Restricted Stock Unit Award Terms and Conditions dated as of February 15, 2019, and (iii) the Elite Subscription and Stock Option Agreement, dated as of February 15, 2019, by and between the Executive and Coty Inc. (the Elite Subscription Agreement), the termination of Executive’s employment under this Agreement shall be treated as a termination other than by reason of Retirement, Disability or death (as such capitalized terms are defined in the applicable plan and/or award agreement).
Accordingly, each of the Executive’s award under the APP with respect to the Company fiscal year ending June 30, 2020, the restricted stock units granted under the ELTIP pursuant to the Restricted Stock Unit Award Terms and Conditions dated as of February 15, 2019, and the options granted under the ELTIP pursuant to the Elite Subscription Agreement, in each case, shall be forfeited without consideration as of the Termination Date. Notwithstanding anything to the contrary contained in the APP, the Executive’s award under the APP with respect to the Company fiscal year ending June 30, 2019 (in an amount of CHF 54’500 (gross)), shall be paid to the Executive in full at such time as is paid to other executives of the Company.
8.
Confidentiality and Restrictive Covenants
The terms and conditions of the Restrictive Covenant Agreement are incorporated by reference and made part of this Agreement as if fully set forth herein.
The Executive acknowledges and agrees that the consideration he is receiving under this Agreement, including the Lump Sum payment set forth in Article 5, fully support the obligations set forth in the Restrictive Covenant Agreement, and, provided that he is paid the amount set forth in Article 5 of this Agreement, he will not be entitled to any further payments under Section 7(b) of the Restrictive Covenant Agreement.





9.
Non-disparagement
The Executive agrees that he has not and shall not make any public statements, statements to the press, statements to present or former employees of the Company, or to any individual or entity with whom, or with which, the Company has a business relationship, whether verbally or in writing, which are disparaging of the Company, its directors, officers, or shareholders. The Executive further confirms that he will not share or make public or publish in any media or form any details of his professional life at the Company in his various roles.
The Company agrees that it shall instruct in writing the members of the executive committee and the board of directors of Coty, Inc. to not make any derogatory, defaming or slanderous comments or statements about the Executive.
Nothing in this Article 9 shall prevent any statements as a consequence of any regulatory or legal obligation or any legal or other court proceedings as required.
The parties agree that the public disclosure of the Executive’s separation from the Company will be correctly described as a retirement from Coty noting the Executive’s age in the disclosure.
10.
Return of Property
The Executive agrees to return to the Company no later than on the Termination Date (or such date as earlier requested by the Company) all property of the Company and any work materials or products or other data with regard to the Company and any affiliate company (irrespective of their form of materialization) which the Executive received or prepared or helped prepare in connection with his employment with the Company or that otherwise came into his possession or control. This includes, but is not limited to, all computer files and other information containing confidential information, and all mailing lists, reports, correspondence, contracts, memoranda, records and other files, computer hardware, software, mobile phones, credit cards, door and file keys, computer access codes or mobile data carriers and instructional manuals.
The Executive further agrees that he will not make or retain any copies, duplicates, reproductions or excerpts of such data or furnish such data to any third party. The Executive agrees to irrevocably delete such data from any private data carrier at the latest on Termination Date (or such date as earlier requested by the Company).
11.
Relocation Expenses; Tax Assistance; Attorneys’ Fees
The Company hereby waives its right to seek reimbursement of the Executive’s relocation allowance under Section 2 of the Employment Agreement. Executive acknowledges and agrees that the Company shall not be obligated or responsible, under Section 4 of the Employment Agreement or otherwise, for any cost associated with the Executive’s (or his family’s) relocation to the Executive’s home country.





The Company hereby agrees to provide the Executive with tax assistance for the Executive’s tax declarations in Switzerland for the 2019, 2020, and 2021 tax years in accordance with Article 2 of the Employment Agreement, notwithstanding the Executive’s termination of employment with the Company.
The Company shall reimburse the Executive for reasonable attorneys’ fees incurred in negotiating this Agreement, up to a maximum of U.S. $15,000, upon submission of appropriate documentation from Executive.
12.
Repurchase of Common Stock
The Executive will sell, transfer, deliver and assign to Coty, Inc. (Coty), and Coty shall purchase from the Executive, all of the Executive’s right, title and interest in and to 453’488 shares of Coty common stock (the Shares), which represent all of the shares of Coty common stock held by the Executive as of the date of this Agreement, free and clear of all security interests, claims, liens, pledges, options, encumbrances, charges, agreements, voting trusts, proxies and other arrangements or restrictions whatsoever, other than those arising under applicable securities laws. The Executive acknowledges that following the closing of such purchase and sale, other than the right to receive the Purchase Price in an amount specified below, the Executive shall have no rights with respect to the Shares. The per Share purchase price shall be the closing price per share of Coty common stock as of the close of regular trading on September 6, 2019 as reported on the New York Stock Exchange (the Purchase Price) and shall be payable in immediately available funds to an account designated by the Executive.  The closing of such transactions shall occur on a date mutually agreed to by the parties which shall be no earlier than September 10, 2019, and no later than September 13, 2019.   The Executive and Coty shall execute and deliver all documents, and take all appropriate actions, reasonably necessary to effect the transfer and repurchase contemplated by this Agreement, including any necessary stock powers.
13.
Assistance
The Executive hereby agrees that he also after leaving the Company will use his best endeavors to reasonably cooperate with the Company and its respective counsel and assistants in connection with any governmental or regulatory investigation and any regulatory or judicial administrative proceeding, arbitration or litigation relating to any material matter (as reasonably determined by the Company) that occurred during his employment. The Company shall reimburse the Executive for any reasonable out-of-pocket expenses (including attorneys’ fees) incurred in connection with any such assistance requested by the Company or its counsel or assistants.
14.
Certificate
The Company undertakes to deliver to the Executive a work certificate within 30 days of the Termination Date.





15.
Personal data
The Executive confirms that upon his departure, he was given ample opportunity to delete any personal documents, data and e-mails and, if necessary, take them with him. The Executive agrees and acknowledges that the Company may freely dispose of any remaining documents, data and emails, even if they include private documents, data or e-mails. The Company is under no obligation to keep them or to draw the Executive's attention to them.
The Company is entitled to block the Executive's email address at the Company at the Termination Date so that no further emails are received, and to inform the persons sending emails to this address with a standard text regarding the Executive's departure.
16.
Release
In consideration of the covenants undertaken by the Company in this Agreement, and except for (x) those obligations created by, arising out of or referred to in this Agreement, (y) the Executive’s rights to indemnification or advancement of expenses in accordance with the Company’s governing documents or any applicable directors’ and officers’ insurance policy covering the Executive, and (z) claims that may not be released under applicable law, the Executive irrevocably and unconditionally, knowingly and voluntarily releases, acquits and forever discharges the Company and any present or former parent corporation, affiliates, subsidiaries, divisions, joint ventures, insurers, attorneys, plan administrators, successors and assigns and the current and former employees, officers, directors, representatives and agents thereof, as well as all otherwise affiliated or related entities or persons (collectively, the Released Parties) of and from any and all claims, suits, liabilities, and grievances, known and unknown he has or may have against the Released Parties arising out of or in connection with his employment relationship with the Company or any affiliate company, including as to the purchase, ownership, and sale of the Shares (other than, for the avoidance of doubt, the Executive’s right to receive the Purchase Price).
17.
Insurance
The Executive is hereby explicitly informed that the mandatory accident insurance coverage provided by the Company will cease thirty-one (31) days after the Termination Date and that after this period he has to provide his own accident insurance. Within thirty-one (31) days of the Termination Date, the Executive may, at his own expense, request an extension of such coverage for a maximum of six (6) months after the Termination Date. In any event, the Executive must inform his health insurance company about the termination of his employment, unless he has already entered into a new employment.
If applicable, within three (3) months after the Termination Date, the Executive may, at his own expense, request to pass over from the Company's collective daily sickness benefits insurance into an individual insurance.





18.
Written Form
This Agreement may only be modified or amended by a document signed by the Parties, whereby an exchange of signed letters is sufficient.
19.
Severability Clause
If any provision of this Agreement be or become invalid or void, the validity of the remaining provisions shall not be affected. In case of invalidity or revocation of a provision of this Agreement the provision is to be replaced by an effective one which comes closest to the economic purpose of the invalid provision. The same shall apply in cases where a gap becomes apparent.
20.
Governing Law | Jurisdiction
This Agreement shall be governed by and construed in accordance with the sub-stantive laws of Switzerland.
The court at the domicile or registered office of the defendant or where the Executive normally carries out his work has jurisdiction to decide any dispute, claim or controversy arising under, out of or in connection with or related to this Agreement.
This Agreement has been executed in 2 (two) originals.
[Signature Page Follows]






Place | date: Geneva, September 9, 2019
For the Company
 
/s/ Herminie Monmignaut Simonetta
/s/ Radi Nabulsi
Name: Herminie Monmignaut Simonetta
Title: SVP General Counsel PB & Europe
Name: Radi Nabulsi
Title: VP Legal PB




Place | date: Amsterdam, September 6, 2019
The Executive
 
/s/ Luc Volatier
 
Mr. Luc Volatier
 







This amended and restated agreement is dated 5 November, 2019
PARTIES
(1)
Coty Services UK Limited, incorporated and registered in England and Wales with company number 00325646 whose registered office is at Eureka Park, Ashford, Kent, TN25 4AQ (the "Company")
(2)
Greerson McMullen of 16 Margaretta Terrace, London SW3 5NU (the "Employee")
BACKGROUND
(A)
The Employee has been employed by the Company since 24 October 2016, as Chief Legal Officer, General Counsel & Secretary Officer under a contract dated 11 October 2016 (the "Employment Agreement") and he has resigned his employment for good reason as of 30 June 2020 (the "Termination Date") in connection with a workplace relocation request, subject to the terms of this agreement. The Company has an existing policy to compensate employees who do not relocate in connection with a workplace relocation. The Employee has been rated 'Very Strong' for FY2019, with a three percent merit increase.
(B)
The Employee and the Company entered into an agreement relating to the termination of the Employee’s employment, which the parties now wish to replace in its entirety with the terms of this agreement.
(C)
The Company enters into this agreement for itself and as agent and trustee for the Company, its subsidiaries or holding companies from time to time and any subsidiary of any holding company from time to time, as subsidiary and holding company are defined in section 1159 of the Companies Act 2006 (each, a "Group Company"), and it is authorised to do so. It is the parties' intention that each Group Company should be able to enforce any rights it has under this agreement, subject to and in accordance with the Contracts (Rights of Third Parties) Act 1999.
AGREED TERMS

1.
INTERPRETATION
The following rules of interpretation apply in this agreement.
1.1    The headings in this agreement are inserted for convenience only and shall not affect its construction.
1.2
A reference to a particular law is a reference to it as it is in force for the time being taking account of any amendment, extension, or re-enactment and includes any subordinate legislation for the time being in force made under it.
1.3
The Schedules shall form part of this agreement and shall have effect as if set out in full in the body of this agreement. Any reference to this agreement includes the Schedules.
1.4    The terms "including" and its variants mean "including, without limitation" and its variants.
1.5
Capitalised terms not defined in this Agreement shall have the meanings given to them in the Employment Agreement.

2.
TERMINATION AND PAYMENTS

2.1
The Employee's employment with the Company and each Group Company will terminate on the Termination Date, unless terminated before the Termination Date for Cause (provided that upon and from the date hereof, subsection (a) of the definition of Cause shall not be applicable) in accordance with the Employment Agreement. The termination of employment is due to the resignation of the Employee for good reason in connection with a workplace relocation request, and notice to terminate the Employment Agreement is hereby given by the Employee as at the date of this agreement. In consideration of the payments and benefits to be provided to the Employee pursuant to this agreement, the Employee and the Company hereby agree to the terms and conditions of this agreement.

2.2
Until and including 31 December 2019 (the "Garden Leave Date" and the separation from





service date as defined under Internal Revenue Code 409A), the Employee will continue to perform his normal duties and hold his customary titles and offices, in accordance with and subject to the Employment Agreement, unless otherwise directed by the Company. For the period immediately after the Garden Leave Date until the Termination Date the Employee will be on Garden Leave and accordingly will, on the Garden Leave Date, resign from all offices he holds with any Group Company and shall not provide services to any Group Company in excess of 20% of his pre-December 31, 2019 level of services. During Garden Leave the terms provided for in clause 14.1.2 of the Employment Agreement (as varied by this agreement) will apply, save that:

(a)
the Employee may continue to develop his professional relationships with law firms and other consultants provided that the Employee does not hold himself out as representing the Company or any Group Company or fail to correct any misunderstanding of his status by any third party caused by the Employee or which becomes apparent to the Employee; and
(b)
notwithstanding any other provisions of the Employment Agreement, the RCA (as defined at clause 4.1) or this agreement, and (for the avoidance of doubt) without forfeiting any remuneration or benefits pursuant to the Employment Agreement or this agreement, the Employee shall be at liberty to obtain alternative employment from this date so long as he remains available to consult by phone on the transition of matters as reasonably required by the Company and provided the Employee complies with section 7(a) of the RCA.    If the Employee obtains alternative employment, the Company will, without the Employee forfeiting any salary, compensation or other benefit hereunder, bring forward the date on which the Employee's employment terminates to such other employment date, in which case such earlier date will be the "Termination Date" for the purposes of this Agreement (and the Employee’s salary for the balance of such garden leave period shall be paid within 30 days of such Termination Date).

2.3
Until 30 June 2020 the Employee will be entitled to receive his normal salary and benefits (as at the date hereof) and will be entitled to receive:

(a)
a bonus for 2019 under the Coty Annual Performance Plan for the fiscal year ending 30 June 2019, of £73,800 payable not later than 30 October 2019; and
(b)
a bonus for 2020 under the Coty Annual Performance Plan for the fiscal year ending 30 June 2020 in an amount equal to the greater of actual achievement and the Employee's Target Award (at a factor of 1), being 60 per cent. of the Employee's then applicable Salary, payable during the 15 day period ending on 30 October 2020.
2.4
It is a condition of the payment and benefits to be provided to the Employee pursuant to this agreement that the Employee will execute a further waiver and release of claims with the same terms and conditions as are set forth in Clause 3 as at the Termination Date (the "Further Release") and that the Adviser will sign and deliver to the Company a further letter in the form attached as Schedule 2 to this agreement (the "Further Certificate").

2.5
Subject to and conditional on: (i) the Employee's compliance in all material respects with the terms of this agreement; (ii) receipt by the Company of this agreement validly executed by the Employee; (iii) receipt by the Company of a letter in the form attached as Schedule 2 to this agreement signed by the Adviser; (iv) receipt by the Company of the Further Release and the Further Certificate; and (v) the Employee not having been terminated for Cause (excluding subsection (a) thereof) before the Termination Date:
(a)
the Company will pay to the Employee the amount of £1,615,440 (the "Termination Payment") by way of compensation for termination of the Employee's employment. The Termination Payment will be paid in two instalments, with the first instalment of £30,000 being paid within 28 days of the Termination Date (and without deduction of income tax and national insurance contributions) and the second instalment of





the balance being paid within 28 days after the date falling six months after the Garden Leave Date less all applicable tax deductions and National Insurance contributions required by law in the ordinary course;
(b)
the Company will pay to the Employee the amount of £390,350 (the "Contractual Payment") inclusive of: (i) the Employee's entitlement to payment under clause 14.2.2 of the Employment Agreement; (ii) a payment in respect of car allowance and employer pension contributions for the period of 24 months beginning on 1 July 2020; (iii) a payment in respect of the Employee's accrued but untaken holiday as at the Termination Date; and (iv) the Employee's three percent merit increase as of October 1, 2019, in each case less all applicable tax deductions and National Insurance contributions required by law in the ordinary course. The Contractual Payment will be paid within 28 days of 1 July 2020;
(c)
the Company shall pay up to £50,000 plus VAT in relation to the provision of outplacement counselling by Manchester Square Partners (or equivalent) to the Employee so long as such costs are incurred not later than 31 December 2021 and, on production of an invoice payable by the Company, the Company shall promptly pay such invoice in 2019;
(d)
the Company shall pay up to £20,000 plus VAT in 2019 in relation to the provision of legal advice regarding the terms of this Agreement to the Employee's solicitors on production of invoices addressed to the Employee but marked payable by the Company and the Company shall promptly pay any such invoice;
(e)
the Employee will continue to benefit from the International transfer policy as in effect on the Date of the Employment Agreement (treating the UK as the home country) and in respect of the costs of relocation to the U.S. (or alternate location that does not cost the Company any additional amount) so long as such eligible relocation expenses are incurred not later than 31 December 2021 and to be paid directly to the provider(s) of the relevant relocation costs on production on an invoice payable by the Company not later than 31 December 2021;
(f)
the Company shall procure the continuation of the Employee's participation in the health and life insurance benefits as are in effect for him as of the date of this agreement and a tax assistance benefit consistent with the benefit provided by the Company in prior years (the cost thereof not to exceed $200,000 per year), in the case of the health and life insurance benefits from the date hereof until 30 June 2022, and in the case of the tax assistance benefit, from the date hereof until the end of 2023 covering the period until 31 December 2022, subject to the following terms: in relation to any such health benefit provided in the U.S., the Employee's coverage will continue for such period - to the extent the Employee is required to pay the applicable premiums, the Employee will be reimbursed for the cost of such premiums on the last day of each of the 18 months immediately after 30 June 2020, followed by a lump sum payment in respect of the outstanding premiums, payable 18 months after 30 June 2020 (it being understood that the Company will use its best efforts to continue the existing arrangement whereby the Employee is not required to pay any premiums for such insurance) which in respect of any period after the Termination Date will be (i) subject to the Employee making a timely election to continue his insurance coverage under COBRA and (ii) effected by the Company making payments of required COBRA premiums directly on the employee's behalf on each monthly due date for such premium. The Employee will be liable for any applicable tax due resulting from the provision of such benefits. Notwithstanding the foregoing, in the event that this clause (f) would subject the Employee or the Company to a material tax or penalty, the parties shall cooperate to provide the Employee with these benefits in a way that does not trigger such tax, cost or penalty, if and to the maximum extent possible;
(g)
the restricted stock units ("RSUs") and stock options held by the Employee will be treated in accordance with the terms and conditions applicable to them (assuming a termination without Cause), it is expected that 60% of the RSUs granted to the Employee on 16 November 2016 will vest on 16 November 2019





(including accrued dividends, to the extent provided for in the applicable terms); and
(h)
the employee shall be entitled to keep (and shall own as of 2020) his work cell phone and laptop computer, provided that he has returned such equipment to the Company as of the Termination Date in order for it to be promptly wiped to ensure the removal of confidential information. The Company will use its reasonable endeavours to ensure the transfer of the Employee's work cell phone number into his own name on or around the Termination Date. The Company shall reimburse any reasonable business expenses incurred by the Employee in the ordinary course of business in accordance with past practice.
2.6
In circumstances where the Employee is, prior to the Termination Date, terminated for Cause the provisions of Clause 2.4 and Clause 3 shall be treated for all purposes as void and unenforceable.

3.
WAIVER OF CLAIMS
    
3.1
The Employee agrees that the terms of this agreement are offered by the Company without any admission of liability on the part of the Company or any Group Company or by Employee and are in full and final settlement of, and the Employee hereby releases, waives and discharges the Company and each other Group Company and their respective current and former officers, directors, employees, workers, agents, shareholders or members, each in that capacity (collectively, "Releasees") from, all and any claims, grievances, liabilities, expenses, lawsuits, proceedings, complaints or rights of action that the Employee has or may have in any jurisdiction against any Releasee arising out of, or relating directly or indirectly to, his employment with the Company (or any other Group Company) or its termination, the holding of any office with the Company or any other Group Company or its termination, whether under common law, tort, contract, statute or otherwise, regardless of whether such claims are, or could be, known to the parties or in their contemplation at the date of this agreement in any jurisdiction and regardless of whether such claims are ripe, mature or choate and including (i) the claims specified in Schedule 1 (each of which is waived by this clause), (ii) any claims under the laws of a jurisdiction other than England that are similar or comparable to any of the claims listed in Schedule 1 (including claims under Title VII of the U.S. Civil Rights Act of 1964, the U.S. Civil Rights Act of 1991, the U.S. Age Discrimination in Employment Act, the U.S. Older Workers Benefit Protection Act, the U.S. National Labor Relations Act, the U.S. Equal Pay Act of 1963, the U.S. Americans with Disabilities Act, the U.S. Rehabilitation Act of 1973, the U.S. Worker Adjustment and Retraining Notification Act, the U.S. Family Medical Leave Act of 1993, the U.S. Employee Retirement Income Security Act, the U.S. Sarbanes-Oxley Act of 2002 any and all state or local law addressing matters similar to those addressed by the foregoing U.S. federal laws), any claims for payments of any nature, including salary, bonuses, holiday pay, profit share, wages, incentive compensation, overtime pay, severance pay, commissions, bonuses and or the monetary equivalent of benefits; and (iii) any claims for the breach of any written, implied or oral contract between the Employee and any Group Company, including the Employment Agreement.
3 .2
The waiver in Clause 3.1 shall not apply to the following:
(a)
any claims by the Employee under or to enforce this agreement;
(b)
claims that cannot be legally waived under applicable law;
(c)
any claims that the Employee may have against the Company or any Group Company in respect of personal injury of which the Employee is not aware and could not reasonably be expected to be aware at the date of this agreement (save for any personal injury claims arising from discrimination in any form);
(d)
any claims in relation to accrued pension entitlements;
(e)
any rights and entitlements pursuant to the terms and conditions of the RSUs and stock options; and
(f)
any claims relating to directors' and officers' liability insurance coverage





or any right of indemnification under the Company's organizational documents or otherwise.
3.3
The Employee warrants that:
(a)
before entering into this agreement he received independent advice from Hayley Robinson of Macfarlanes LLP (the "Adviser") as to the terms and effect of this agreement and, in particular, on its effect on his ability to pursue any complaint before an employment tribunal or other court and, before receiving the advice, the Employee disclosed to the Adviser all facts and circumstances that may give rise to a claim by the Employee against any Releasee;
(b)
the Adviser has confirmed to the Employee that the Adviser is a solicitor holding a current practising certificate and that there is in force a policy of insurance covering the risk of a claim by the Employee in respect of any loss arising in consequence of the Adviser's advice;
(c)
the Adviser shall sign and deliver to the Company a letter in the form attached as Schedule 2 to this agreement; and
(d)
the only claims that the Employee has or may have against any of the Releasees (whether at the time of entering into this agreement or in the future) relating to his employment with the Company or any other Group Company or its termination are specified in Clause 3.1 and the Employee is not aware of any facts or circumstances that may give rise to any claim against any Group Company or its officers, employees or workers other than those claims specified in Clause 3.1.
The Employee acknowledges that the Company acted in reliance on these warranties when entering into this agreement.

3.4
The Employee acknowledges that the conditions relating to settlement agreements under section 147(3) of the Equality Act 2010, section 288(2B) of the Trade Union and Labour Relations (Consolidation) Act 1992, section 203(3) of the Employment Rights Act 1996, regulation 35(3) of the Working Time Regulations 1998, section 49(4) of the National Minimum Wage Act 1998, regulation 41(4) of the Transnational Information and Consultation etc. Regulations 1999, regulation 9 of the Part-Time Workers (Prevention of Less Favourable Treatment) Regulations 2000, regulation 10 of the Fixed-Term Employees (Prevention of Less Favourable Treatment) Regulations 2002, regulation 40(4) of the Information and Consultation of Employees Regulations 2004, paragraph 13 of the Schedule to the Occupational and Personal Pension Schemes (Consultation by Employers and Miscellaneous Amendment) Regulations 2006, regulation 62 of the Companies (Cross Border Mergers) Regulations 2007 and section 58 of the Pensions Act 2008 have been satisfied.

3.5
The waiver in Clause 3.1 shall have effect irrespective of whether or not, at the date of this agreement, the Employee is or could be aware of such claims or have such claims in his express contemplation (including such claims of which the Employee becomes aware after the date of this agreement in whole or in part as a result of new legislation or the development of common law or equity). As of the date hereof, the Company is not aware of any claims against, or material breach of obligations by, the Employee.

3.6
The Employee agrees that, except for the payments and benefits provided for in this agreement he shall not be eligible for any further payment from any Group Company relating to his employment or its termination
    
3.7
The Employee acknowledges that he has been given the right to take up to twenty-one (21) days to consider this agreement, and to the extent the Employee signs this agreement prior to such twenty-first (21st), the Employee knowingly and voluntarily waives his right to consider this agreement for the remainder of such period.

3.8
The Employee has the right to revoke this agreement within seven (7) days following the date it is executed by the Employee. Any revocation of this agreement must be in writing and received by the Company by the close of business on the seventh day following Employee's





execution of this Agreement and shall be delivered to the Company, Attention: Sophie Hanrot.

4.
RESTRICTIVE COVENANTS, CONFIDENTIALITY AND REFERENCE

4.1
The Employee acknowledges that the terms of the Confidentiality, Non-Competition and Non-Solicitation Agreement attached as Annex I to the Employment Agreement (the "RCA") will continue to apply after the Termination Date, including in respect of restrictive covenants and confidentiality, save that the Employee will be released from his obligations under sections 7 and 9 of the RCA with effect from I July 2020 and subsections 1l(b) (i) shall be deemed deleted from the RCA as of the date hereof and provided that the Company shall, acting reasonably, consider in good faith any request for consent sought by the Employee pursuant to section 7(a) of the RCA.

4.2
The Employee agrees to keep the existence and terms of this agreement and, the circumstances concerning the termination of the Employee's employment confidential, except where the Company has already made it public, such disclosure is to HM Revenue & Customs, the Internal Revenue Service ("IRS"), any regulatory or law enforcement body or supervisory authority or otherwise as required by law (and nothing in this agreement limits the Employee's ability to communicate with or participate in any investigation or proceeding, including by providing documents or other information, without notice to the Company, regarding possible violations of securities laws that may be conducted by such regulatory or law enforcement body or supervisory authority), or (where necessary or appropriate) to:
(a)
the Employee's spouse, civil partner or partner, immediate family or legal or professional advisers, provided that they agree to keep the information confidential or anyone to whom the Company has disclosed the terms of this agreement after the date hereof; or
(b)
the Employee's insurer for the purposes of processing a claim for loss of employment.

4.3
The Company may also disclose the existence and terms of this agreement to any Group Company's officers, directors, employees or legal or professional advisers, provided that they are bound to keep the information confidential.
4.4
The Employee shall not make, or cause to be made, any adverse, derogatory, defaming, slanderous or harmful comment or statement about any of the Releasees. The Employee shall not do anything which shall, or may, bring the Company, or any Group Company, its or their current or former directors, shareholders or employees into disrepute and the Company shall instruct in writing the members of the executive committee and the board of directors of Coty, Inc. to not make any adverse, derogatory, defaming, slanderous or harmful comment or statement about the Employee.

4.5
Nothing in this Clause 4 or in the RCA shall prevent the Employee from:
(a)
making a protected disclosure under section 43A of the Employment Rights Act 1996 or equivalent US law;
(b)
making a disclosure to a regulator regarding any misconduct, wrongdoing or serious breach of regulatory requirements, or reporting a criminal offence to any law enforcement agency;
(c)
co-operating with any law enforcement agency regarding a criminal investigation or prosecution; or
(d)
enforcing his rights under this agreement or providing sworn testimony.
    
4.6
Nothing in this Clause 4 shall prevent the Company from making such disclosure as it is required to make by law and/or the rules of any regulatory or supervisory authority or to operate in its ordinary course of business.

4.7
The Company will provide, at the Employee's request, a reference in respect of the Employee





and will respond to all oral enquiries for such a reference, confirming the Employee's dates of employment and positions.

5.
MISCELLANEOUS

5.1
Taxation. The parties believe that the first £30,000 of the Termination Payment will be tax free, as a termination award under the threshold within the meaning of sections 402A(l) and 403 of the Income Tax (Earnings and Pensions) Act 2003. The Employee shall indemnify the Company on a continuing basis in respect of any income tax or National Insurance contributions (save for employers' National Insurance contributions) due in respect of the payments any benefits payable or provided under this Agreement (and any related interest, penalties, costs and expenses) save for income tax or national insurance contributions which the Company deducts at source in accordance with this agreement and for any interest, penalties, costs and expenses arising from the Company's willful default. The Company shall give the Employee reasonable notice of any demand for tax which may lead to liabilities on the Employee under this indemnity and shall provide the Employee with reasonable access to any documentation the Employee may reasonably require to dispute such a claim (provided that nothing in this clause shall prevent the Company from complying with its legal obligations with regard to HM Revenue and Customs, the IRS or other competent body).
The parties intend this agreement to be exempt from or to comply with Section 409A of the U.S. Internal Revenue Code of 1986, as amended ("Section 409A"), and that it be interpreted accordingly. The Employee acknowledges and agrees, however, that Company does not guarantee the tax treatment or tax consequences associated with any payment or benefit arising under this agreement, including, without limitation, to consequences related to Section 409A. To the extent any payment hereunder is determined to be "deferred compensation" within the meaning of Section 409A, each such payment will be treated as a separate payment for purposes of Section 409A (and no such payment will be subject to any offset or netting pursuant to this or another agreement). If the Employee is a "specified employee" (within the meaning of Section 409A and as determined by the Company), any payment hereunder that is determined to constitute "deferred compensation" that is payable to the Employee as a result of a "separation from service" within the meaning of Section 409A will not be made or provided before the date that is six months after the date of the Employee's separation from service (or his earlier death or a change in ownership or effective control, within the meaning of Section 409A), if and solely to the extent required by Section 409A.
To the extent that any reimbursement, fringe benefit or other, similar plan or arrangement in which the Employee participates provides for a "deferral of compensation" within the meaning of Section 409A, (a) the amount of expenses eligible for reimbursement provided to the Employee during any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to the Employee in any other calendar year, (b) the reimbursements for expenses for which the Employee is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred, (c) the right to payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit and (d) the reimbursements shall be made pursuant to objectively determinable and nondiscretionary Company policies and procedures regarding such reimbursement of expenses.
The Employee shall be solely responsible for taxes imposed on Employee by reason of any compensation or benefits provided under this agreement and all such compensation and benefits shall be subject to applicable withholding requirements. Furthermore, the Employee has discussed the contents of this agreement with his tax adviser and is aware of the tax consequences to the Employee based on the payments and benefits set forth herein, including but not limited to consequences under Section 409A. Employee acknowledges he is responsible for reporting the receipt of any income under this agreement and remitting the appropriate income tax to the appropriate tax authorities, as required, to the extent not withheld by the Company. The Employee agrees, to the fullest extent permitted by applicable law, to indemnify and hold harmless the Company, and its affiliates, agents, partners, officers, directors, employees or shareholders, against all taxes, additional taxes, claims, liabilities (including interest and penalties) and expenses of whatever nature under Section 409A of the Code arising





as a result of the payments contemplated by this agreement.
    
5.2
Entire Agreement. Each party, on behalf of itself and, in the case of the Company, as agent for any Group Companies acknowledges and agrees with the other party (the Company acting on behalf of itself and as agent for each Group Company) that: (a) this agreement, the RCA and the provisions of the Employment Agreement which survive termination of employment constitute the entire agreement between the parties and any Group Company and supersede and extinguish all agreements, promises, assurances, warranties, representations and understandings between them whether written or oral, relating to its subject matter; (b) in entering into this agreement it does not rely on, and shall have no remedies in respect of, any statement, representation, assurance or warranty (whether made innocently or negligently) that is not set out in this agreement; and (c) it shall have no claim for innocent or negligent misrepresentation or negligent misstatement based on any statement in this agreement.

5.3
Variation. No variation of this agreement shall be effective unless it is in writing and signed by the parties (or their authorised representatives).

5.4
Third Party Rights. Except as expressly provided elsewhere in this agreement, no person other than the Employee and any Group Company shall have any rights under the Contracts (Rights of Third Parties) Act 1999 to enforce any term of this agreement. This does not affect any right or remedy of a third party which exists, or is available, apart from that Act.

5.5
Governing Law; Jurisdiction.    This agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales. Each party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this agreement or its subject matter or formation (including non-contractual disputes or claims).

5.6
Subject To Contract And Without Prejudice. This agreement shall be deemed to be without prejudice and subject to contract until such time as it is signed by both parties and dated, when it shall be treated as an open document evidencing a binding agreement.

5.7
Counterparts.    This agreement may be executed and delivered in any number of counterparts, each of which, when executed, shall constitute a duplicate original, but all the counterparts shall together constitute the one agreement.

5.8
No Admission.    The terms of this agreement are offered without any admission of liability on the part of any Releasee or by Employee.

5.9
Ambiguities. Attorneys for all parties have participated in the negotiation of this agreement and, thus, it is understood and agreed by the Company and the Employee that the general rule that ambiguities are to be construed against the drafter shall not apply to this agreement.







This agreement has been entered into on November 5th, 2019.

Signed by Pierre Laubies for and on behalf of Coty Services UK Limited

/s/ Pierre Laubies
Director


/s/ Greerson McMullen
Signed by Greerson McMullen

 
 







Exhibit 21.1
Coty Inc.
Subsidiary List
as of September 30, 2019
Entity Name
Domestic Jurisdiction
Coty Argentina S.A.
Argentina
Coty Australia Holdings PTY Ltd.
Australia
Coty Australia Legacy Pty. Limited
Australia
Coty Australia PTY. Limited
Australia
Gresham Cosmetics Pty Ltd
Australia
HFC Prestige International Australia PTY Ltd
Australia
Jemella Australia Pty Limited
Australia
Revolver Distribution PTY Ltd.
Australia
Coty Beauty Austria GmbH
Austria
HFC Prestige Products N.V.
Belgium
Coty Brasil Comércio Ltda
Brazil
Lancaster do Brasil Cosmeticos Ltda.
Brazil
Savoy Indústria de Cosméticos S.A.
Brazil
StarAsia Distributions (Cambodia) Ltd.
Cambodia
HFC Prestige International Canada, Inc.
Canada
TJoy Holdings Co. Ltd.
Cayman Islands
Coty Cosméticos Chile Limitada
Chile
Coty China Holding Limited
China
Coty Hong Kong Distribution Ltd.
China
Coty International Trade (Shanghai) Co., Ltd.
China
Coty Prestige Shanghai Ltd.
China
HFC (Shanghai) Cosmetics Co., Ltd
China
Nanjing Yanting Trade Co. Ltd.
China
Suzhou Ganon Trading Co., Ltd.
China
Suzhou Jiahua Biochemistry Co. Ltd
China
HFC Prestige Service Costa Rica S.R.L.
Costa Rica
Coty Ceska republika, s.r.o.
Czechia
GHD Scandinavia ApS
Denmark
HFC Prestige International Denmark ApS
Denmark
Coty Holdings UK Limited
England and Wales
Quest Beauty Limited
England and Wales
HFC Prestige International Finland Oy
Finland
Coty S.A.S.
France
Coty France S.A.S.
France
Else France S.A.S.
France
Fragrance Production S.A.S.
France
GHD France S.á r.l.
France
HFC Prestige Holding France
France
Coty Beauty Germany GmbH
Germany
Coty Brands Management GmbH
Germany
Coty Germany Holding GmbH
Germany
Coty Services and Logistics GmbH
Germany
Ghd Deutschland GmbH
Germany
HFC Prestige Manufacturing Cologne Germany GmbH
Germany
HFC Prestige Manufacturing Germany GmbH
Germany

1



HFC Prestige Products GmbH
Germany
HFC Prestige Service Germany GmbH
Germany
Sebastian Europe GmbH
Germany
Wella Grundstuecks- und Vermoegensverwalturngs GmbH & Co. KG
Germany
Zadafo Verwaltungsgesellschaft mbH
Germany
Wella Hellas MEPE
Greece
Chi Chun Industrial Co. Ltd.
Hong Kong
Coty Hong Kong Limited
Hong Kong
Coty INT Hong Kong Limited
Hong Kong
Coty Prestige Shanghai (HK) Ltd.
Hong Kong
Coty Prestige Southeast Asia (HK) Limited
Hong Kong
GHD Hong Kong Limited
Hong Kong
Ming-De Investment Co. Ltd.
Hong Kong
Super Globe Holdings Ltd.
Hong Kong
Coty Hungary Kft.
Hungary
Coty India Beauty and Fragrance Products Private Limited
India
Wella India Private Limited
India
PT StarAsia Distributions Indonesia
Indonesia
PT. Coty Prestige Southeast Asia Indonesia
Indonesia
Coty Ireland Ltd.
Ireland
Coty UK&I Limited
Ireland
HFC Prestige Manufacturing Ireland Ltd.
Ireland
Coty Italia S.R.L.
Italy
GHD Italia S.r.l.
Italy
HFC Prestige Japan Godo Kaisha
Japan
OPI-Japan K.K.
Japan
Coty Korea Ltd.
Korea, Republic Of
HFC Prestige International Holding Luxembourg SARL
Luxembourg
HFC Prestige International Luxembourg SARL
Luxembourg
Coty INT Malaysia Sdn. Bhd.
Malaysia
Coty Prestige Southeast Asia (M) Sdn. Bhd.
Malaysia
Coty Beauty Mexico, S.A. de C.V.
Mexico
Coty México, S.A. de C.V.
Mexico
HFC Cosmetics S. de R.L. de C.V.
Mexico
HFC Prestige International S. de R.L. de C.V.
Mexico
Coty Lancaster S.A.M.
Monaco
Coty B.V.
Netherlands
Coty Global 1 B.V.
Netherlands
Coty Global 2 B.V.
Netherlands
Coty Global 3 B.V.
Netherlands
Coty Global 4 B.V.
Netherlands
Coty Global 5 B.V.
Netherlands
Coty Global Holdings B.V.
Netherlands
Coty Investments B.V.
Netherlands
Coty International B.V.
Netherlands
Coty International Holding B.V.
Netherlands
Coty Management B.V.
Netherlands
HFC Prestige International Netherlands Holding B.V.
Netherlands
Lancaster B.V.
Netherlands
HFC Prestige International New Zealand Limited
New Zealand

2



Jemella New Zealand Limited
New Zealand
GHD Scandinavia NUF (Norwegian Branch)
Norway
HFC Prestige International Norway AS
Norway
Coty Prestige Southeast Asia Philippines, Inc.
Philippines
Coty Eastern Europe sp. z.o.o.
Poland
HFC Prestige Service Poland Sp. z.o.o.
Poland
Coty Beauty Portugal S.A.
Portugal
HFC Prestige International Puerto Rico LLC
Puerto Rico
Coty Cosmetics Romania SRL
Romania
Bourjois Paris LLC
Russian Federation
LLC Capella
Russian Federation
Russwell Ltd
Russian Federation
Coty Arabia Trading Company LLC
Saudi Arabia
Coty Scot 1 LP
Scotland
Coty Scot 2 LP
Scotland
Coty Asia Pte. Ltd.
Singapore
Coty Prestige Southeast Asia Pte. Ltd.
Singapore
Coty Singapore Pte. Ltd.
Singapore
Coty Southeast Asia Pte. Limited
Singapore
HFC Prestige International Operations Switzerland SARL Singapore Branch
Singapore
HFC Prestige International Singapore Pte. Ltd.
Singapore
Coty Slovenská Republika s.r.o.
Slovakia
Coty Beauty South Africa (PTY) Ltd.
South Africa
Coty South Africa (Proprietary) Limited
South Africa
Good Hair Day South Africa (Proprietary) Limited
South Africa
Coty Beauty Spain, S.L.U.
Spain
Coty Spain S.L., Sociedad Unipersonal
Spain
GHD Spain, S A U
Spain
HFC Prestige International Sweden AB
Sweden
Coty International S.a.r.l.
Switzerland
HFC Prestige International Holding Switzerland Sàrl
Switzerland
HFC Prestige International Operations Switzerland Sàrl
Switzerland
Coty Beauty Swiss Sàrl
Switzerland
So Be Cosmetics S.A.
Switzerland
Coty Prestige (Taiwan) Ltd.
Taiwan, Province Of China
StarAsia Taiwan Co., Ltd.
Taiwan, Province Of China
Coty Prestige Southeast Asia (Thailand) Company Limited
Thailand
HFC Prestige Manufacturing (Thailand) Ltd.
Thailand
HFC Prestij Satış ve Dağıtım Ltd. Şti.
Turkey
Coty Distribution Emirates L.L.C.
United Arab Emirates
Coty Middle East Fzco
United Arab Emirates
Coty Regional Trading FZE
United Arab Emirates
HFC Prestige International Operations SARL
United Arab Emirates
Beamly Ltd.
United Kingdom
Beauty International Ltd.
United Kingdom
Bourjois Limited
United Kingdom
Coty Brands Group Limited
United Kingdom
Coty Export U.K. Ltd.
United Kingdom
Coty Manufacturing UK Ltd.
United Kingdom
Coty Services U.K. Ltd.
United Kingdom

3



Coty U.K. Limited
United Kingdom
Coty UK&I Ltd
United Kingdom
Del Laboratories (U.K.) Limited
United Kingdom
ghd BondCo plc
United Kingdom
GHD Group Holdings Limited
United Kingdom
GHD Group Limited
United Kingdom
GHD Holdings Limited
United Kingdom
HFC Prestige Manufacturing UK Ltd
United Kingdom
HFC Prestige Products Ltd.
United Kingdom
HFC Prestige Service UK Ltd
United Kingdom
Jemella Group (Holdings) Limited
United Kingdom
Jemella Group Limited
United Kingdom
Jemella Limited
United Kingdom
Lancaster Group, Ltd.
United Kingdom
Lion/Gloria Bidco Limited
United Kingdom
Lion/Gloria Holdco Limited
United Kingdom
Lion/Gloria Midco 2 Limited
United Kingdom
Lion/Gloria Midco 3 Limited
United Kingdom
Lion/Gloria Midco Limited
United Kingdom
Lion/Gloria Topco Limited
United Kingdom
Rimmel International Ltd.
United Kingdom
GHD Professional, North America, Inc.
United States - CA
HFC Prestige Products, Inc.
United States - CT
Beamly Inc.
United States - DE
Calvin Klein Cosmetic Corporation
United States - DE
Coty Brands Management Inc.
United States - DE
Coty Holdings, Inc.
United States - DE
Coty Inc.
United States - DE
Coty International LLC
United States - DE
Coty US Holdings Inc.
United States - DE
Coty US LLC
United States - DE
DLI International Holding I LLC
United States - DE
DLI International Holding II Corp
United States - DE
Galleria Co.
United States - DE
Graham Webb International, Inc.
United States - DE
HFC Prestige International U.S. LLC
United States - DE
Launch Beauty LLC
United States - DE
O P I Products, Inc.
United States - DE
Rimmel Inc.
United States - DE
The Wella Corporation
United States - DE
Noxell Corporation
United States - MD
Coty Beauty Vietnam Company Limited
Viet Nam


4


Exhibit 31.1
Certification

I, Pierre Laubies, certify that:

1.                                      I have reviewed this quarterly report on Form 10-Q of Coty Inc.;
2.                                      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.                                      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.                                      The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)                                     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)                                     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)                                      Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)                                     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.                                      The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a)                                     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)                                     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:    November 6, 2019                    
 
/s/Pierre Laubies
 
 
Pierre Laubies
 
 
Chief Executive Officer
 




Exhibit 31.2
Certification

I, Pierre-André Terisse, certify that:

1.                                      I have reviewed this quarterly report on Form 10-Q of Coty Inc.;
2.                                      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.                                      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.                                      The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)                                     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)                                     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)                                      Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)                                     Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.                                      The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a)                                     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)                                     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:    November 6, 2019
 
/s/Pierre-André Terisse
 
 
Pierre-André Terisse
 
 
Chief Financial Officer




Exhibit 32.1
Certification
Pursuant to Rule 13a-14(b) or
Rule 15d-14(b) and 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The quarterly report on Form 10-Q for the quarter ended December 31, 2018 (the “Report”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 6, 2019
 /s/Pierre Laubies
 
 
Pierre Laubies
 
Chief Executive Officer


The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.





Exhibit 32.2
Certification
Pursuant to Rule 13a-14(b) or
Rule 15d-14(b) and 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The quarterly report on Form 10-Q for the quarter ended December 31, 2018 (the “Report”) of the Company fully complies with the requirements of section 13(a)  or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

                
Date: November 6, 2019
/s/Pierre-André Terisse
 
 
Pierre-André Terisse
 
Chief Financial Officer


The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.